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Abstract
Many parasites and their hosts have developed a mode of coexistence during
their evolution. The parasitic nematode Acanthocheilonema viteae can downreg-
ulate the immune response of their host by inducing immunoregulatory cytokines
such as interleukin-10 (IL-10). In this thesis, I developed mathematical mod-
els of IL-10 regulation to investigate the mechanims of IL-10 regulation. These
models were based on literature evidences and in vitro data on the production
of IL-10 in macrophages in response to Av17, an immunomodulatory protein of
A. viteae. IL-10 expression requires stimulation of the mitogen-activated protein
kinases (MAPK) ERK and p38. I proposed that a negative feedback mechanism,
acting at the signalling level, is responsible for transient IL-10 upregulation that
can be followed by a sustained plateau. The model assumes that Av17 leads to
phosphorylation of ERK and p38 and that IL-10 expression induced by Av17
in macrophages was tyrosine kinase sensitive and dependent on activation of
both MAP kinases. These assumptions were validated with experimental data
on ERK and p38 activation. To further elucidate how the activation of ERK
and p38 regulates IL-10 expression, I combined theoretical and experimental ap-
proaches. I hypothesised several alternative ways of signalling regulation and
developed a method of model selection that combines the theoretical predic-
tions with experimental evidences and selected a model that was able not only
to fit experimental data but also to correctly predict independent experimental
data. Experimental testing of the in silico generated hypotheses identified dual
specificity phosphatase (DUSP) 1 and 2 as integral feedback regulators in Av17
triggered macrophages in vitro and in vivo. In particular, dedicated experiments
showed that DUSP1 was responsible for regulation of ERK and p38 phosphoryla-
tion and controlled the IL-10 expression in Av17 stimulated macrophages. Thus,
this systems biology approach showed that Av17 handles activation and deactiva-
tion pathways of MAP kinases to induce a regulatory phenotype in macrophages.
Furthermore, a sensitivity analysis suggested that p38 affects ERK via DUSP,
but ERK does not affect p38, revealing an autocrine negative feedback between
the signalling components. This model prediction was also validated experimen-
tally. In general, host immune regulation mechanisms should be robust against
variations, e.g., by parasites like A. viteae. This prompted me to test the robust-
ness of the selected model against extrinsic and intrinsic variations using a Monte
Carlo approach. I compared the previously selected model, which implements
an integral feedback, with a model with transient feedback. The results support
the notion that the model with integral feedback is more robust against intrinsic
and extrinsic variations than the model with transient feedback, in the specific
case of IL-10 production and regulation in macrophages after their exposal to
immunomodulatory molecules of the parasite A. viteae. Taken together, based
on a systems biology approach that successfully combines theoretical knowledge
and experimental expertise this thesis proposes a mechanism that describes how
the parasite A. viteae interacts with the macrophages of its host in order to
induce the expression of the immunoregulatory cytokine IL-10.
v

Zusammenfassung
Der parasitische Nematode Acanthocheilonema viteae kann die Immunantwort
seines Wirtes abschwächen, indem er in diesem die Produktion immun-regulatorischer
Cytokine Interleukin-10 (IL10) induziert. In dieser Arbeit entwickelte ich spe-
zifische mathematische Modelle um die Mechanismen der IL10 Regulation zu
erforschen. Die Annahmen des Modells waren:
1. Av17, ein immun-modulatorisches Protein von A. viteae, zur Phosphory-
lierung der MAP-Kinasen ERK und p38 führt;
2. Av17 induzierte IL10 ist ERK und p38 abhängig.
Beide Annahmen waren in Übereinstimmung mit experimentellen Ergebnissen
zur Aktivierung von ERK and p38. Weiter habe ich mehrere Signalregulations-
modelle getestet und eine Methode entwickelt, die theoretische und experimen-
telle Ansätze kombiniert. Von hier aus konnte ich ein Modell auswählen, dass
unabhängige experimentelle Daten korrekt vorhersagt. Modelle selection identifi-
zierten die Duale-Spezifizität Kinasen (DUSP) als integrale Rückkopplungsregu-
latoren dieses Systems. Eine Sensitivitätsanalyse zeigte, dass p38 durch DUSP,
ERK beeinflusst, das Gegenteil aber nicht. Dieser Befund legt eine autokrine
Rückkopplung der Signalkomponenten nahe, die auch experimentell bestätigt
werden konnte. Allgemein mssen die immunoregulatorischen Mechanismen im
Wirt robust gegen Strungen, z.B. durch Parasiten wie A. viteae, sein. Dies ver-
anlasste mich mit Hilfe eines Monte-Carlo Ansatzes die Robustheit der ausge-
wählten Modelle gegenüber Variationen zu testen. Ich verglich das zuvor ausge-
wählte Modell und ein Modell mit transienter Rückkopplung. Das Resultat lies¨
darauf schlies¨en, dass in diesem Fall die integrale Rückkopplung robuster ge-
genüber Variationen ist als eine transiente Rückkopplung. Insgesamt verbindet
der systembiologische Ansatz meiner Arbeit erfolgreich theoretisches Wissen mit
experimenteller Expertise um einen Mechanismus vorzuschlagen, der beschreibt,
wie der Parasit A. viteae mit Makrophagen seines Wirtes interagiert, um IL10
Exprimierung zu induzieren.
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1. Thesis overview
Parasitic nematodes, in particular A.viteae, express an immunomodulatory protein,
a cystatin known as Av17, which binds to the macrophages of their host and induce
IL-10 expression, to dampen the immune response of the host. The first question of
this thesis was to understand which pathways lead to IL-10 production in Av17 stim-
ulated macrophages. To answer this question, I constructed mathematical models,
based on literature evidences and experimental data on IL-10 kinetics. These models
suggest that Av17 activates the MAPKs ERK and p38 to induce IL-10 expression.
The available experimental data, showed that IL-10 has transient dynamics in Av17-
stimulated macrophages. Therefore, I included a feedback regulation mechanism in
the mathematical model (chapter 4.1). I fitted three different models to the available
experimental data on IL-10 kinetics (chapter 4.2). These three different models in-
cluded a model without regulation, one other where IL-10 dephosphorylates ERK via
phosphatase activation and another where IL-10 dephosphorylates ERK via kinase
inhibition. Model fitting showed that a model without regulation is not able to fit
the experimental data as well as the other two models with regulation. Therefore, I
rejected this model (chapter 4.3) and did two more general and theoretical studies:
I compared phosphatase activation with kinase inhibition (chapter 5) and I did a
sensitivity analysis by perturbing specific nodes and checking their influence on the
overall network (chapter 6). To check the assumption of the model, that Av17 ad-
dresses both ERK and p38 to induce IL-10 expression in macrophages, these MAPKs
were experimentally tested. The experimental evidences showed that both ERK and
p38 are transiently activated after Av17 stimulation, and that both MAPK are essen-
tial to induce IL-10 production, confirming this hypothesis of the model (chapter 9).
To quantitatively validate the model predictions, I compared the in silico predictions
of both models for ERK and p38. Both models suggest that ERK is transient and
p38 is sustained, but the experimental data show that both kinases are transient
(chapter 9.1), therefore, a model refinement was necessary to better represent the
biological data.
This propelled me to the next question of my thesis: what are the signalling events
that regulate ERK and p38 and, consequently, IL-10 dynamics? (chapter 8). I as-
sumed that ERK and p38 can be regulated through three different ways: 1) IL-10
itself deactivates the MAPKs expression. 2) Phosphatases such as DUSPs deacti-
vate the MAPKs. 3) An independent molecule (i.e., a molecule not activated by
Av17) deactivates the MAPKs. I investigated systematically the possible biologically
significant combinations of regulation at the signalling level. This yielded 35 mod-
els with alternative regulation mechanisms (chapter 10). I fitted the models several
times, using different fitting algorithms and different parameters constraints and I
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ranked them using Akaike Information Criteria (AIC). The best model incorporated
a regulation mechanism through IL-10. Experimental validation of IL-10 kinetics
when IL-10 blocking antibodies are added, suggested that IL-10 did not play a role
in regulating the MAPKs. Consequently, I selected the best ranked model that did
not contain a regulation mechanism through IL-10. The selected model suggested
that DUSP deactivates ERK and p38 (chapter 11). To verify the predicted role
of DUSPs, experimental testing revealed that several DUSPs were upregulated in
macrophages after Av17 treatment in vivo and in vitro. The kinetics of the in silico
DUSP matched the experimental ones. With this model at hand, I did a sensitiv-
ity analysis to understand how perturbations on ERK or p38 affect the expression
levels of P38, ERK, IL-10 and DUSP. Effectively, this analysis revealed that DUSP
mediates crosstalk between individual MAPKs and this was supported by experi-
mental evidences (chapter 11.4). Moreover, it revealed a successfull systems biology
approach, where experiments interlace with mathematical modelling.
Then, in the third part of my thesis, I did a theoretical analysis on the robustness
of this selected model, when compared with a model where the MAPK regulation
happens through IL-10. The type of feedback distinguishes both models: the model
with regulation by DUSP has an integral feedback and the model with regulation
by IL-10 has a transient feedback (chapter 13). I studied the robustness of each
model with respect to internal and external random perturbations using a Monte
Carlo analysis (chapter 14), and the results suggested that integral feedback is more
robust to internal and external random perturbations than transient feedback. To
understand if the type of feedback was determinant on the robustness of the model,
I proned the arms that provide feedback on both models and I did the same analysis
presented in chapter 14. Results suggest that the feedback mechanism clearly pro-
vides robustness to the selected model (chapter 15). I therefore conclude that this
parasite-host interaction has been shaped to be robust throughout their evolutionary
history. Figure 1.1 depicts the whole process described above.
2
Figure 1.1.: Flow diagram describing the steps of this thesis.
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2. General introduction
Biology is a complex science. It is amazing how nature generates life. From the
interaction of two single cells and billions of years of evolution one complex organism
emerges. When I ask myself “How does this happen?”, I feel submersed in the sea
of data and information available. Distilling knowledge from all this data and infor-
mation can be a monstrous task. How can we learn from biology? The application
of mathematics to understand that natural science can be a quaint and desirable
approach for answering questions of this nature. Mathematics’ etymology comes
from the Greek, meaning learning, study, science. Applying mathematics in biology
means using abstract mathematical tools to describe and eventually solve a concrete
question in biology. The field of intersection between mathematics and biology is
often termed systems biology. A definition-in-a-box for this emerging field in science
is difficult to attain. According to Noble (2008),
"Systems biology...is about putting together rather than taking apart,
integration rather than reduction. It requires that we develop ways of
thinking about integration that are as rigorous as our reductionist pro-
grammes, but different....It means changing our philosophy, in the full
sense of the term"
2.1. General considerations on modelling
“As far as the laws of mathematics refer to reality, they are not certain;
and as far as they are certain, they do not refer to reality.” - Albert
Einstein.
Cells interact with each other, process signals and can change their phenotype
according to their stimuli and, although surrounded by sometimes more noise than
signal, build together a functional and interacting living organism.
Although mathematical modelling is one efficient and elegant way to test various
hypotheses based on known evidences, according to Box and Draper (1987), “essen-
tially, all models are wrong, but some are usefull”. Mathematics provides a myriad
of methods to formally represent a complex system, from its qualitative description
to its quantification. Nevertheless, there is no unifying principle that can describe all
processes in any system. The nature of the complex system and of the specific ques-
tion the investigator wants to answer will dictate which method will best describe the
problem at hand. Only so, mathematical modelling can improve the understanding
of biological systems. In fact, mathematical models are approximations of reality. So,
5
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there might be more than one model that describes the biological problem at hand.
To select the best model, it is important to keep in mind some characteristics. First,
how well can the model estimate the unknown parameters, given the experimental
data? Second, overparametrization must be avoided. When generating a model, it is
important to keep in mind the principle of parsimony: while keeping the number of
parameters as low as possible, include all the components and reactions paramount to
describe the system and where data are available. Model validation follows model se-
lection: model predictions are compared with independent experimental data. Figure
2.1 depicts the steps of modelling generation, selection and validation.
Figure 2.1.: Schematic representation of possible modelling steps. With prior knowledge
based on observations/literature/experiments, the investigator proposes an hypothesis, that
leads to the development of a conceptual model. From this conceptual model, a mathematical
model that receives experimental data as input, can be developed. Model validation consists
of comparing a model prediction with an independent experiment. If the model is not able
to correctly predict the data, the model must be refined, leading to a redefinition of the
conceptual model. The cycle composed by the triad “Conceptual Model - Mathematical
Model - Model validation” is complete when the model can correctly predict the data and,
now, the model predictions can be compared with the initial hypothesis.
Combining dry lab with wet-lab experiments has several advantages. First of all, the
process of model conception brings together all the elements and their interactions,
allowing a “bird’s-eye” view of the problem at hand. Second, with a mathematical
model it is possible to undergo simulations before doing in vitro experiments, which
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saves time, money and, most importantly, the environment (Klipp et al., 2009).
Finally, in silico experiments allow testing single element perturbations, which may
not be possible or realistic to undergo in vitro or in vivo.
2.1.1. From the conceptual model to the mathematical model
Carefull thinking about the problem at hand is critical for delineating an approach
to tackle the hypothesis being tested. Conceptual model development, containing
prior knowledge is the first step. At this stage, theoreticians and experimentalists
brain storm to distinguish between relevant and not so relevant information. This
is dependent on the objective of the study. For instance, a model for studying the
aerodynamics of a butterfly will not account for the colour patterns of its wings,
which is a valid omission (Voit and Torres, 2002); this would be an important factor
under the scope of biodiversity, for instance.
With the decision of the model framework comes the decision of the mathemat-
ical method to formalise the conceptual model. Models can be linear or nonlinear,
deterministic or stochastic, static or dynamic. Methods like petri nets (Sackmann
et al., 2009), boolean networks (Wittmann et al., 2009), ordinary differential equa-
tions (Figueiredo et al., 2009), game theory (Hammerstein, 1981) - which was specif-
ically applied to understand host-parasite interactions (Renaud and de Meeüs, 1991)
- linear programming (Figueiredo, 2005), difference equations (Koehncke et al., 2009)
or statistical methods (Hilgenboecker et al., 2008) have been successfully applied to
solve biological problems. Each method has its advantages and drawbacks, and the
decision on the method is dependent on the question to answer and the available data.
I used ordinary differential equations to develop the mathematical models present in
this thesis.
Ordinary Differential Equations
Ordinary Differential Equations (ODE) are an effective way of mathematically de-
scribing the dynamics of a biochemical reaction network through its components
and reactions. These equations allow the in silico representation of qualitative com-
plex systems and the quantification of their parameters, providing insights into their
emergent properties. According to Klipp et al. (2009), the dynamic behaviour of a de-
terministic system can be described, in vector notation, by the differential equations:
dx
d t = x˙ = f(x,p, t) (2.1)
where x = (x1,x2, ...,xn)T, f = (f1, f2, ..., fn)T and p = (p1, p2, ..., pm)T. The
vector x represents the elements of the network, p are the parameters and f are the
functions that will normally represent the production and degradation reactions of
element xi.
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Steady state
A system is considered in steady state when its amplitude variation over time is
constant. The steady state is assumed for fast reactions (seconds or milliseconds),
when compared to slow reactions, like cell growth. As the variations over time are
constant, the differential equations of system 2.1 will be zero.
dx
d t = 0 (2.2)
The law of mass action
The law of mass action is the simplest way of describing biochemical reaction kinetics.
It states that the reaction rate is proportional to the concentration of the reactants,
to the power of its molecularity (Klipp et al., 2009). Equation 2.3 represents the
chemical equation of a reaction where one molecule of S1 and one other of S2 bind
to form 2 molecules of P, where the number two is the molecularity of P.
S1 + S2 
 2P (2.3)
In case the velocity of this reaction, i.e. its rate, obeys the law of mass action, the
mathematical representation of the reaction rate is given by equation 2.3.
v = v+ + v− = k+ · S1 · S2 − k− · P 2 (2.4)
which can be described by the following ODE system:
d
dt
S1 =
d
dt
S2 = −v (2.5)
d
dt
P = 2v (2.6)
To obtain the dynamic behaviour of the elements S1, S2 and P of the ODE system
2.6, this has to be integrated (Klipp et al., 2009).
Other types of biochemical kinetics
The reaction rate of a reaction might not only depend on the concentration of the
substrates. In the case of reactions catalysed by enzymes, it has been observed
that the reaction velocity saturates at a certain substrate concentration. The most
famous rate law describing a saturation kinetics is the Michaelis-Menten kinetics,
which describes an enzyme (E) catalised transformation of a substrate S into the
product P , as described by the chemical equation 2.7.
E + S → E + P (2.7)
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The Michaelis-Menten reaction rate is given by:
v =
VmaxS
Km + S
(2.8)
where Vmax is the maximum reaction rate and Km is the half saturation constant
that gives the concentration of substrate for which the reaction rate is half of its
maximum. The Michaelis-Menten rate law can be mathematically derived from mass
action kinetics using a quasi steady state assumption. For details, see Klipp et al.
(2009); Goldbeter and Koshland (1981).
Another useful biochemical reaction rate law, is the Hill kinetic. It cannot be as
easily derived from mass action principles as the Michaelis-Menten kinetics, but has
been used widely to describe reactions that display phenomena of cooperativity. This
means that molecules with higher affinity cooperatively act together, increasing the
reaction rate in a non-proportional way. The biochemical reaction of Equation 2.7
can be mathematically described by Equation 2.9.
v =
VmaxS
h
Khm + S
h
(2.9)
where h is the Hill coefficient, that measures the cooperativity in a binding process,
Vmax is the maximum reaction rate and Km is the half saturation constant that gives
the concentration of substrate for which the reaction rate is half of its maximum.
2.1.2. Parameter estimation
A specific model can have different dynamic behaviours, depending on its parameter
values. Therefore, a fundamental feature of parameter estimation is to minimise the
error between the observed data (or experimental evidences) and the model predic-
tions. There are several methods to estimate the parameters of a specific mathemat-
ical model. Please refer to Kühn (2010); Ljung (1999); Mueller (2002); Seber and
Wild (2003) for a detailed description on parameter estimation methods. I used the
software package COPASI (Hoops et al., 2006) to estimate the unknown parame-
ters of my models. COPASI assumes that parameter estimation is an optimisation
problem. The objective function of this problem is the squared distance between the
measured experimental data and the model (SSR), represented in Equation 2.10.
SSR (p) =
n∑
i=1
ωi (xi − fi (p))2 (2.10)
where ωi are the weights of each element to be fitted, xi are the experimental data
points and pi are the parameters to be estimated. The parameters are calculated to
minimise the objective function S (P ). To solve this optimisation problem, COPASI
uses global estimation algorithms. Global estimation algorithms have the advantage
of avoiding local minima (Seber and Wild, 2003). In the particular parameter esti-
9
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mation problem of the models studied in this thesis, I used two stochastic methods
available in the referred software package, namely, simulated annealing and evolu-
tionary programming. These are two typical global estimation algorithms used to
estimate unknown parameters.
Simulated annealing is a popular global optimisation algorithm to calibrate un-
known parameters inspired by statistical mechanics1. Evolutionary and genetic algo-
rithms are optimisation methods inspired by biology and evolution. These algorithms
generate a mutation (random perturbation) and construct a fitness function, which
is used to filter out not useful mutations (Baldi and Brunak, 2001).
2.1.3. Model discrimination
Model discrimination follows two critical and essential steps in the investigation of a
scientific problem: first, carefull thinking about the problem to solve is essential to
have a well defined scientific question, second, well defined experimental design will
provide good quality experimental data. At this stage, an investigator can define a
model that expresses the information gathered by the data (Burnham and Anderson,
2002). With a core model at hand, alternative hypothesis can be considered.
According to Burnham and Anderson (2002), there are two main methods as a
means of selecting a model: information criteria and hypothesis testing. Hypothesis
testing has been used for longer than information criteria, but the former needs
more computational power than the latter, specially when there are several high-
dimensional candidate models. This renders information criteria a more attractive
method to discriminate between models.
A very simple way to test how close the model reflects the experimental data is by
simply calculating the distance between the experimental data point and the corre-
sponding simulated point. This computationally light method, known as the sum of
squared residuals and represented in Equation 2.10 has, however, heavy drawbacks: it
does not take into account the complexity of the model neither if the overall dynamics
of the experimental and the simulated values agree.
Therefore, to discriminate between candidate models, I used the Akaike Informa-
tion Criterion.
Akaike Information Criterion
The Akaike Information Criterion (AIC) is a method of model discrimination that
uses the Kullback-Leibler distance as a fundamental basis for model selection. The
Kullback-Leibler distance denotes the information lost when model g is used to ap-
proximate model f . It assumes that the real model f is known, as well as its parame-
ters (θ). In most of the situations, the data (y) are known, but the real model f is not
and the parameters are estimated (θˆ). In these situations, the expected estimated
Kullback-Leibler distance is used, instead of the minimal Kullback-Leibler distance
1Simulated annealing has its origin in mettalurgics, where certain metals must be cooled slowly, or
annealed, and other must be cooled rapidly, or quenched.
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over the set of candidate models. Aikaike found a relationship between Kullback-
Leibler distance and the maximised log likelihood. This relationship is expressed in
the formula 2.11 and has become known as the AIC.
AIC = −2 log
(
L
(
θˆ|y
))
+ 2k (2.11)
The AIC is an effective way of selecting a “best approximating model” (Burnham
and Anderson, 2002). It attributes a value to a model, calculated based on the
weighted sum of squared residuals between estimated model curve and experimental
data (SSR), number of parameters (k) and number of data points (n), rather than
having a simple measure of the directed distance between two models. The AIC
provides an estimate of the expected and relative distance between the fitted model
and the (unknown) particular system that actually generated the observed data.
Equation 2.11 can be simplified to equation 2.12, if all the candidate models assume
normally distributed errors with constant variance (Burnham and Anderson, 2002).
AIC = 2k+ n
(
ln 2piSSR
n
+ 1
)
(2.12)
For a small sample size (n > k− 1), the AIC is corrected to the expression:
AICc = AIC +
2k(k+ 1)
n− k− 1 (2.13)
It is valuable to emphasise here the importance of carefull thinking when defining
the candidates models, because AIC provides a relative measure of the goodness of
one model, compared to the remaining models in the set. This best model might
poorly describe the real system under study.
2.2. Noise in biology
Biological data are noisy. Cells can distinguish between noise and signal, filtering
out the noise, even with a weak signal to noise ratio. This feature reveals robustness
to variability in biological interactions.
2.2.1. Robustness of biological systems
Defining robustness is a challenge for today’s biologists. A robust system keeps its
performance under a wide range of conditions even if a part of the system fails.
Living organisms sense changes in their environment and adapt to them, hence,
sensitivity and robustness walk hand in hand. On the one hand, robustness is the
insensitivity of a particular property of the system (Yi et al., 2000), on the other hand,
the ability of a living system to survive depends on how quickly it is able to sense
changes in the environment, or a failure in a module, and adapt to it by activating
alternative modules as fast as possible. Robustness is an important property of
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biological systems, because it assures the function of a biological system, in spite
of parameter perturbations (Alon, 2007). Negative feedback mechanisms provide
robustness to perturbations in the internal components of the system or to extrinsic
noise (Sauro and Kholodenko, 2004; Klipp et al., 2009).
In Part III of this thesis, I studied the robustness of two mathematical models, by
analysing the output response of the system when this was subject to perturbations
in: 1. its internal components (intrinsic noise), 2. in the input (extrinsic noise).
I simulated intrinsic noise by applying the formula:
p˜i = U [pi · 0.8, pi · 1.2] (2.14)
where p˜i is the perturbed parameter value, which is sampled from an uniform distri-
bution, U [a, b]. This distribution is limited between a = pi · 0.8 and b = pi · 1.2.
To simulate the extrinsic noise, I used the following formula:
s(t) = s0[1+ ξ(t)] (2.15)
where ξ(t) is a Gaussian distribution with mean=0 and standard deviation=0.1 and
s0 the initial amplitude value.
Stochastic modelling permit to investigate the effect of intrinsic and extrinsic noise.
A model with stochastic simulations allows the simulation of random phenomena
(Wilkinson, 2006). It is described by a set of random variables, each with a certain
probability of happening in a defined time interval. Each random variable describes
different realisations of the mathematical model. These independent random vari-
ables (or white noise) are, commonly, independent and normally distributed variables
(Ljung and Glad, 1994). Hence, a stochastic system has a set of solutions instead of
having a single solution.
Monte Carlo analysis allows the simulation of these different realisations of a spe-
cific variable X of the model at hand (Wilkinson, 2006). These computational meth-
ods rely on defining an universe of possible inputs and randomly sampling from this
set of inputs using a probability distribution. The output is then deterministically
calculated for each element of the universe of inputs. This creates then a set of values
that will constitute the final result of the Monte Carlo analysis.
2.2.2. General notions on feedback
Feedback is a mechanism where the output of a system feeds back into the input.The
aim of a feedback loop is to control, or tune, the present and future output of a system
using the output information of the past. The concept of feedback is present in our
everyday life and in such discrepant fields as engineering, economics and finances,
politics, education and life sciences.
Feedback motifs are present in biology and life sciences in the most different forms
and scales. This concept is present in molecular motifs like signalling cascades, as
well as in ecological networks and climate science, among many others.
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Positive feedback vs. negative feedback
There are different forms of feedback. This section briefly distinguishes positive and
negative feedback. Positive feedback loops provide an output with high gain and
low stability and, eventually, bistability, whereas negative feedback loops provide
an output with low gain and high stability. Both types of feedback can lead to
oscillations.
One example of negative feedback in biology is homeostasis2. Positive feedback
can be observed, for instance, in the process of lactation.
Integral feedback
Integral feedback is a mechanism, commonly used in control theory, that ensures
that the system tracks the desired response, even in the presence of noise (Yi et al.,
2000). A system with this type of feedback integrates over time the error between the
desired and the effective output (Alon, 2007). This ensures the desired output level,
regardless of the variations in the parameters. This is an effective way of providing
robustness in a system, by adaptation or desensitisation. Figure 2.2 shows the block
diagram of a general system with integral feedback.
Figure 2.2.: Block diagram of a control system that implements integral feedback. u repre-
sents the input, y1, the output before the feedback, y0 is the desired output, y is the difference
between both and x is this integrated difference.
2The term of homeostasis was coined by Cannon (1932), but its concept was studied before by
Claude Bernard, as the milieu intérieur.
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x˙ =y (2.16)
y =k (u− x)− y0 (2.17)
This guarantees perfect adaptation. Theoretically, y(t) → 0 when t → ∞. There
are two ways of achieving perfect adaptation: through integral feedback, as explained
above, or through fine-tuning (Alon, 2007). In this method, the parameters are tuned
for the system to yield the desired output, i.e., y(t)→ 0 when t→∞. This method
has two drawbacks: is harder to implement and the parameters are highly sensitive
to allow this fine tuning. Indeed, one characteristic of integral feedback is to provide
robustness. According to Alon (2007), ‘...biological circuits have robust designs such
that their essential function is nearly independent of biochemical parameters that
tend to vary from cell to cell.” Regulation motifs may provide robustness against
cellular noise.
2.2.3. Signalling networks as regulation motifs
Signal transduction is the process by which a cell transforms an initial signal or
stimulus to one other, through the action of specific enzymes that catalyse specific
reactions. Signal transduction pathways play a pivotal role fighting against invading
pathogens. Mitogen activated protein kinases (MAPK) cascades transduce an extra-
cellular signal and regulate specific intracellular activities, which are dependent on
the extracellular stimulus. These highly conserved cascades respond to a myriad of
stimuli and mainly control gene expression and regulation. Nevertheless, the com-
plex interactions that control the different activities of the MAPK cascades are not
yet fully understood. Mathematical models have been used to better comprehend
the mechanisms behind the different behaviours of the same cascade. Heinrich et al.
(2002) implemented mathematical models for different topologies of the receptor-
stimulated kinase/phosphatase signalling cascades and analysed key parameters that
characterise the signalling pathways (signal amplitude, signalling time and signal du-
ration). Sasagawa et al. (2005) constructed a mathematical model of Extracellular
signal-regulated kinases (ERK) signalling based on literature findings and predicted
ERK dynamics in response to increases of the epidermal growth factor (EGF) and
nerve growth factor (NGF). Both studies show that the same MAPK pathway can
have a sustained or transient activation, as experimentally shown by Marshall (1995)
and Santos et al. (2007).
Signalling cascades have “built-in” control functions at different levels that con-
trol the signal strength and duration. These cascades activate phosphatases that
implement a negative feedback regulation and limit the cell response. Regulators like
dual specificity phosphatases (DUSPs) limit the response of macrophages to extra-
cellular stimuli (Chi et al., 2006). Specifically, DUSP-1 exerts a feedback control on
the signalling cascades p38, ERK and JNK (Wang and Liu, 2007; Li et al., 2009).
Activated ERK and P38 induces the production of DUSP-1 (Ananieva et al., 2008;
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Hu et al., 2007), which in turn deactivates ERK and P38, respectively, accounting
for the transient behaviour of this MAPK (Wang and Liu, 2007; Li et al., 2009).
This phosphatase is a major regulator of the immune response and controls the
production of pro- and anti- inflammatory cytokines (Chi et al., 2006).
2.2.4. Sensitivity analysis
Mathematical modelling adds explanatory power to the experimental analysis, when
studying the overall impact of perturbations on the biological network. In silico
analysis of a biological network allows the investigator to perturb each element of
the network and observe the impact of this perturbation in the other elements. This
type of study would be a practically impossible task to undertake in vivo or in vitro:
it is a question of time, money and resources.
The mathematical formula to calculate the sensitivity of an element to a specific
perturbation, is the following:
S =
∆O
O
· p
∆p
(2.18)
(O is the output and p is the perturbed parameter. ∆{O, p} is the difference
between the perturbed and unperturbed values of {O, p}). If |S| = 1, means that the
ratio of perturbation in p is equal to its effect in the output O. If |S| >> 1, then the
system is sensitive to perturbations in the specific parameter p. The sign of S reflects
the effect of the perturbation in the output. When S is positive, an inhibition of p
will reflect an inhibition of O, else, if S is negative, an inhibition of p means that O
will be amplified, whereas an amplification of p translates into an inhibition of O.
2.2.5. Time-dependent sensitivity analysis
Time-dependent sensitivity analysis (TDSA) was proposed by Ingalls and Sauro
(2003) and describes the system’s sensitivity along a temporal trajectory. This
method is a derivation of the Metabolic Control Analysis (MCA) theory, which anal-
yses the distribution of control between the elements of a network in steady state
(Heinrich and Rapoport, 1974). Nevertheless, in transient or oscillatory systems, it
might be important to study the sensitivity along non-steady trajectories (Ingalls
and Sauro, 2003). Given an initial condition s (0) and a set of parameter values p0,
which form a vector q0, the time-varying concentration sensitivity is given by:
Rsiqj (t) =
∂si(t, q)
∂qj |qj=qj0
= lim
∆q→0
∂i(t, q+ ∆qj)− si(t, q)
∆qj
(2.19)
These response coefficients can be scaled (Kühn, 2010):
R˜sq(t) =
qj
si(t, q)
∂si(t, q)
∂qj
|qj=qj0 (2.20)
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The coefficients are defined by the ordinary differential equation:
d
dt
∂s(t, q)
∂q
= N
(
∂s(t)
∂q
∂υ(t)
∂s
+
∂υ(t)
∂q
)
(2.21)
where N is the stoichiometric matrix and ∂s(t)∂q and
∂υ(t)
∂s are the concentration and
parameter elasticities, respectively (Ingalls and Sauro, 2003; Kühn, 2010). MCA has
proven to be a valid method on interpreting the control distribution of a system in
steady state. A way of analysing the control distribution along a time trajectory,
renders TDSA a valuable tool for the analysis of transient systems.
2.3. General considerations on the immune response to
parasites
2.3.1. The immune system at a glance
Immunity has its etymology in the Latin word Immunitas, which meant exemption
from civic duties and legal prosecution, offered to Roman Senators (Abbas et al.,
2000). Today, according to Murphy et al. (2008), "immunology is the study of the
body’s defense against infection". This defence happens at the cellular and molecu-
lar level. The network of cells and molecules that provide immunity is the immune
system, and their coordinated response to infection is the immune response. The
early immune response to infection by potential pathogens is known as innate im-
munity. It takes place right after infection and has low specificity: reacts in the
same way to different types of infection and is the gatekeeper of the adaptive im-
mune response (Medzhitov and Janeway, 2000). This response is not specific to any
pathogen nor provides lasting immunity. Nevertheless, it discriminates between self
and nonself. Phagocytes involved in the adaptive immune response (macrophages,
neutrophils and dendritic cells), recognise specific patterns of molecular structure
and simple molecules, which are common to many pathogens but are not present on
the body’s own cells. These evolutionary conserved patterns are known as pathogen-
associated molecular patterns (PAMPs), and the referred immune cells recognise
them through receptors known as pattern recognition receptors (PRRs) (Murphy
et al., 2008). Specifically, macrophages are in the first line of defence, after the
pathogen breaks the physical and chemical barriers imposed by the skin, epithe-
lia and gut. Through the PPRs, macrophages recognise the infecting agents with
PAMPs and are activated in order to engulf these infective agents. Macrophages
secrete specific cytokines and chemokines, which will signal to and attract other cells
containing the specific receptors.
The innate immune system mounts an attack against the nonself and this triggers
the adaptive immune response.
The adaptive immune response, present only in vertebrates, takes place between
one or five days after infection. This response is more efficient on eliminating infec-
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tion than the innate immune system, because is directed to the specific pathogen.
Lymphocytes are the players of the adaptive immune response. These cells have on
their surface highly specialised antigen receptors, which can recognise and respond
to the specific antigen (Murphy et al., 2008).
The cells of the immune system arise from pluripotent hematopoietic stem cells,
in the bone marrow. These cells can derive into lymphoid progenitors or myeloid
progenitors. The cells that characterise the adaptive immune response and derive
from lymphoid progenitors, are the T cells and the B cells 3. T cells and B cells possess
antigen receptors and are distinguished by their differentiation sites. T cells have
their origin in the thymus and B cells, in the bone marrow. The B cells mediate the
humoral arm of the adaptive immune response and are responsible for the production
of antibodies (which are highly specific and have memory). The T cells differentiate
into effector T-cells, with a variety of functions that fall in three classes: killing,
activation and regulation (Murphy et al., 2008). I will focus on the Helper T cells,
which stimulate B cells to differentiate and produce antibodies, or can also activate
macrophages to become more efficient on the phagocytosis of pathogens. Helper T
cells can polarise to different types of cells, e.g. Th1, Th2, Tregs or Th17. In the
next section, I will focus on Th1 and Th2 cells.
The classical Th1/Th2 paradigm
The innate and/or adaptive immunity takes the decision to polarise T cells to, e.g.,
Th1, Th2, Tregs or Th17 cells, depending on the specific cytokine environment (Spell-
berg and Edwards, 2001), controlling the effector immune response (O’Garra and
Vieira, 2007).
The Th1 cells stimulate type I immunity, profiled by the production of IL-2, IFN-γ,
lymphotoxin-α and phagocyte activity. Production of IL-4, IL-5, IL-9, IL-13 and IL-
10 characterises the Th2 response, which stimulates the type II immunity, with high
levels of antibody production (Spellberg and Edwards, 2001). The definiton of Th1
or Th2 cells depends on the expression of IL-4 and IFN-γ. Th1 cells express IFN-
γ but not IL-4 and Th2 cells express IL-4 but not IFN-γ (Spellberg and Edwards,
2001).
Nevertheless, these responses are not exclusive, meaning that in specific situations,
Th1 cells can mount a type II immunity response (Spellberg and Edwards, 2001). For
instance, Th1 cells can produce IL-10 to regulate themselves (O’Garra and Vieira,
2007).
Interleukin-10
Interleukin-10 (IL-10) is a cytokine with immunoregulatory properties. It is at the
interface between the adaptive and the innate immune response and executes its
function on wide range of immune cells (Moore et al., 2001; Asadullah et al., 2003).
3Natural Killer cells (NK cells) also derive from lymphocytes, but are part of the innate immune
system. These cells lack antigen specificity.
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IL-10 was first described as cytokine synthesis inhibitory factor (CSIF) from mitogen
stimulated T helper 2 cells inhibiting pro-inflammatory cytokine production such as
interferon-gamma in T helper 1 cells (Fiorentino et al., 1989; Zdanov et al., 1995).
Later studies revealed that many other cell types from the innate and adaptive arm of
the immune response can produce IL-10 under certain conditions. These cells include
monocytes, macrophages, B cells, eosinophils and mast cells (Asadullah et al., 2003)
and more recently also various IL-10 producing T cell subsets have been described,
including different regulatory T cell populations, CD8+ T cells and Th1 cells (Vieira
and O’Garra, 2007). Macrophages, in particular, are a source and target of this
cytokine. One important function of IL-10 is to control and ultimately annihilate
excessive immune responses during infections and autoimmunity (Moore et al., 2001;
Asadullah et al., 2003). It inhibits the production of pro-inflammatory cytokines
in macrophages and other cell types (Vieira and O’Garra, 2007). This moderates
for instance overshooting T-cell responses during inflammation which otherwise may
lead to immunopathological damage (Moore et al., 2001; Couper et al., 2008). IL-10
deficient mice develop spontaneous colitis under normal conditions (Kühn et al., 1993)
and are more prone to immunopathology in general, being able to clear infection by
intracellular pathogens more effectively than wild type mice (Schnoeller et al., 2008;
Vieira and O’Garra, 2007). These observations highlight the importance of IL-10 as
a cytokine with immunoregulatory properties.
2.3.2. Parasitic nematodes and their interference with the immune
system
Parasites are organisms that live in or on a different organism, obtaining sustenance
from it and thus damaging it (Lucius and Loos-Frank, 2008). Parasitic nematodes,
in particular, are highly specialised multicellular organisms that dwell in specific
niches within their hosts. In all of these sites, the host steadily attacks the parasites
with various immune responses. However, many parasitic nematode species reach life
spans of years. This fact is due to elaborated immune evasion mechanisms set up by
the parasitic nematodes. Onchocerca volvulus, for example, is a parasitic nematode
that causes the tropical disease River Blindness and is transmitted to its human host
by the arthropode Simulium yahensecan. This parasite remains in its host for more
than 10 years (Plaisier et al., 1991) and affects around 20 million people wordwide.
The rodent nematode Acanthocheilonema viteae is a model organism, used to study
basic questions of host-parasite interaction, such as host immune responses and par-
asite immune evasion mechanisms (Figueiredo et al., 2009). Infections by parasitic
nematodes induce a type 2 T helper cell (Th2) response, which can efficiently kill
parasitic nematodes by triggering immune effector mechanisms. Nevertheless, these
organisms seem to modify this immune response and vigorous effector mechanisms do
not develop. One way to dampen the immune effector mechanism is to stimulate the
production of anti-inflammatory cytokines such as IL-10. This cytokine minimises
inflammatory reactions and, as a consequence, compromises the ability of the host
to kill the parasites. This balance allows survival of parasites and hosts. Blunted
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Th2 responses may represent a benefit for the host. The ensuing downregulation of
effector mechanisms decreases diseases that result from an imbalance of the immune
system, like autoimmune responses and allergies. Indeed, often a correlation between
allergies or auto immune diseases, and the lack of exposure to infective agents, such
as parasites has been observed (Araujo and de Carvalho, 2006; Carvalho et al., 2006).
Moreover, long-lasting worm infections can change the regulation of the immune sys-
tem, with a tendency to reduce allergies (Lucius and Loos-Frank, 2008). These facts
can be a breakthrough in developing pharmaceuticals to fight immune disorders. Ac-
cordingly, it is of major importance to identify the molecules and pathways that
modulate host immune responses.
A. viteae cystatin (Av17) is a cysteine protease inhibitor that is constantly secreted
by the nematode. It has important functions in immune processes such as anti-
gen processing and presentation (Hartmann and Lucius, 2003; Gregory and Maizels,
2008). Furthermore, recombinant A. viteae cystatin (rAv17) has recently been shown
to specifically inhibit allergic and inflammatory responses in mice (Schnoeller et al.,
2008). In this scenario, rAv17 induced IL-10 production in macrophages as a key
element of immunomodulation. To understand the mechanisms leading to IL-10 pro-
duction in Av17 stimulated macrophages, and the consequent modulation of the host
immune response, I developed several mathematical models.
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Part I.
IL-10 production and regulation in
macrophages stimulated with an
immunomodulator of parasitic
nematodes
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3. Synopsis
This part is an extended version of Figueiredo et al. (2009). The experiments here
referred, in vitro IL-10 protein and il-10 mRNA kinetics, were conducted in the De-
partment of Parasitology, Humboldt-Universität, Berlin. The experimental details are
described in Figueiredo et al. (2009).
Parasitic nematodes modulate the immune response of their hosts by inducing
immunoregulatory cytokines such as IL-10. To determine the mechanisms of IL-10
production in Av17 stimulated macrophages, I developed mathematical models of IL-
10 production and regulation. I proposed that IL-10 expression requires stimulation
of the MAP kinases ERK and p38 and that a negative feedback mechanism, acting
at the signalling level, is responsible for transient IL-10 production. Specifically, I
implemented two valid models with negative feedback that account for the experi-
mental data of in vitro IL-10 kinetics. I assumed that this feedback can be achieved
by kinase inhibition or phosphatase activation. I refer to kinase inhibition if the
feedback regulation is achieved by inhibiting the reaction that phosphorylates ERK.
I refer to phosphatase activation if the feedback regulation is achieved by promoting
the reaction that dephosphorylates ERK. I did a comparative study on these two
types of feedback by varying the amplitude signal (Av17) and comparing the kinet-
ics of the different elements of the network. I also studied the concepts of maximal
amplitude, width at half amplitude, steady state, integral and overshoot when the
models were faced with input variations. Moreover, to understand the influence of
one element of the network on one other, I performed a sensitivity analysis (eq. 2.18)
by varying each parameter and checking its influence on the steady state of phospho
-ERK phospho -p38 and IL-10.
23

4. Modelling IL-10 production and
regulation in macrophages exposed to
Av17
4.1. Construction of the mathematical models
The promoter region of the il-10 gene in macrophages contains binding sites for
several transcription factors, of which SP1 and STAT3 are examples (Lucas et al.,
2005). These transcription factors regulate the gene expression and are controlled
by ERK (Yang et al., 2007) and p38 (Gee et al., 2007). In a sequential mechanism,
the ERK signalling cascade remodels the chromatin of the il-10 promoter region by
phosphorylating its Histone 3 (H3) sites and the p38 signalling pathway activates the
transcription factors SP1 and STAT3 (Lucas et al., 2005). These transcription factors
bind to the phosphorylated H3 sites and thereby initiate il-10 gene expression (Zhang
et al., 2006). Moreover, CREB induces IL-10 expression in macrophages (Cao et al.,
2006) and monocytes (Gee et al., 2007). Macrophages express the IL-10 receptor
complex on their surface, suggesting a feedback regulation by IL-10. A negative
autoregulatory role for IL-10 is suggested for LPS or lipoprotein stimulated IL-10
production in monocytes and monocyte-derived macrophages (de Waal Malefyt et al.,
1991; Giambartolomei et al., 2002; Staples et al., 2007; Ward et al., 2005). Based on
these evidences, I assumed that Av17 activates the signalling pathways ERK and p38
in macrophages, leading to IL-10 production, and I hypothesised that IL-10 regulates
itself via a negative feedback mechanism. In this mechanism, secreted IL-10 binds to
the macrophages and deactivates the ERK signalling pathway. This is represented
in Figure 4.1.
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Figure 4.1.: Schematic representation of IL-10 induction and regulation. Av17 binds to the
macrophage and activates the p38 signalling pathway (that will activate the transcription
factors SP1 and STAT3) and the ERK signalling pathway (that will phosphorylate the H3
site of the il-10 promoter region). These transcription factors bind to this promoter site,
inducing il-10 mRNA expression. IL-10 protein is subsequently produced and secreted. I
assumed that extracellular IL-10 binds to the IL-10 receptor of macrophages (IL-10r) and
deactivates phospho-ERK, either by kinase inhibition or by phosphatase activation, hence
regulating its own production in a negative feedback loop.
With these evidences, I developed mathematical models on IL-10 regulation in
Av17 stimulated macrophages. These models reflect two different hypothesis about
regulation mechanisms, namely, that regulation can be achieved by kinase inhibition
or phosphatase activation. Model development was based on the principle of parsi-
mony. In order to keep the number of parameters as small as possible, I included
only those components and processes that I considered paramount to describe the
systems dynamics and where data were available (see Table 4.1 and Figure 4.2 for all
components and reactions included in the models).
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Process Equation
ERK phosphorylation on
Av17 stimulation and
constitutive
dephosphorylation
Model 1:
v1 = k1 · [ERKt −ERKp (t)] · j ·
s (t) /
[
1+ kf · IL10e(t)h
]
v2 = k2 ·ERKp (t)
Model 2:
v1 = k1 · [ERKt −ERKp (t)] · j · s (t)
v2 = k2 ·ERKp (t) · IL10e (t)h
P38 phosphorylation on Av17
stimulation and constitutive
dephosphorylation
v3 = k3 · j · s (t) · [p38t − p38p (t)]
v4 = k4 · p38p (t)
Transcription factor activation
and constitutive deactivation
v5 = k5 ·At · p38p (t)
v6 = k6 ·Ap (t)
Histone phosphorylation and
dephosphorylation
v7 = k7 ·ERKp (t) ·H3 (t)
v8 = k8 ·H3p (t)
Complex formation, constituted
by the transcription factor
bound to the phosphorylated H3
site and constitutive
disaggregation
v9 = k9 ·H3p(t) ·Ap(t)
v10 = k10 ·H3Ap(t)
Induction of il-10 mRNA
expression v11 = k11 ·H3Ap(t)
Degradation of il-10 mRNA v12 = k12 · IL10m(t)
Transcription and translation to
IL-10 intracellular protein v13 = k13 · IL10m(t)
Degradation of IL-10
extracellular protein v14 = k14 · IL10e(t)
Table 4.1.: Description of reactions and its equations for both models of IL-10 production
and regulation. s(t) is the stimulus (input) and corresponds to Av17. j corresponds the the
different concentrations that Av17 may have.
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Assumption ERKt = ERK(t) +ERKp(t)
p38t = p38(t) + p38p(t)
Table 4.2.: Assumptions for the equations’ system of table 4.1.
dERKp
dt
= v1 − v2 (4.1)
dp38p
dt
= v3 − v4 (4.2)
dAp
dt
= v5 − v6 + v9 − v10 (4.3)
dA
dt
= v6 − v5 (4.4)
dX0
dt
= v8 − v7 (4.5)
dX1
dt
= v7 − v8 + v9 − v10 (4.6)
dX2
dt
= v10 − v9 (4.7)
dIL10m
dt
= v11 − v12 (4.8)
dIL10e
dt
= v13 − v14 (4.9)
I propose two distinct feedback mechanisms via IL-10 (model 1 and model 2) and
compare it to a model with no feedback (model 0). Model 1 assumes promotion of
ERK dephosphorylation via IL-10 (kinase deactivation). Model 2 assumes inhibition
of ERK phosphorylation via IL-10 (phosphatase activation). The components and
reactions of these models are described in Table 4.1. I have implemented these models
using ODEs (equations’ system 4.9 and reactions’ description at Table 4.1) and fitted
them to experimental data on il-10 mRNA and IL-10 protein time series, and il-10
mRNA half life.
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Figure 4.2.: Mathematical model of IL-10 production and regulation. The model receives
the input stimulation (Av17) as a step function (from 0 to 1), which activates ERK and
p38. Phospho-ERK phosphorylates the H3 sites of the il-10 promoter region. Phospho-p38
activates the set of transcription factors (A) necessary to induce il-10 gene expression (il-
10m). Transcription and translation take place. IL-10 is secreted by the macrophage (IL-10e)
and promotes the feedback regulation. I hypothesised that extracellular IL-10 (IL-10e) binds
to the macrophage and deactivates phospho-ERK, either by kinase deactivation (model 1) or
by phosphatase activation (model 2). These two models have in common the regulation by
negative feedback.
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4.2. Model fitting to the data
The different models were fitted to experimental data on IL-10 protein and il-10
mRNA time series and il-10 mRNA half-life (please refer to (Figueiredo et al., 2009)
for the experimental details). Figure 4.3(a) shows IL-10 protein and il-10 mRNA
time series. The maximum relative il-10 mRNA expression was measured at 2 h
after stimulation. After 4 h, the mRNA levels reached background levels again. IL-
10 protein in the cell supernatant was detectable after 2-3 h, showed a steady increase
over time until 8 h, and declined after 14-24 h.
I fitted the models to the data using a global optimisation procedure, described in
section 2.1.2 and using the software COPASI (Hoops et al., 2006). The details of the
particular fits can be found in Appendix A.2. The different regulation models fit the
experimental data for il-10 mRNA and IL-10 secreted protein. The Hill coefficient of
model 2, expressed as h in equation v2 of the respective model, yielded a value close
to 1. Therefore, in order to minimise the number of parameters, I did not consider
the parameter h. Figures 4.3(b) 4.3(c) and 4.3(d) show the model fittings to the
experimental data of Figure 4.3(a).
These data show that model 0 is not able to fit the decrease of IL-10 production
observed experimentally, keeping it at a sustained level, whereas the models with
feedback regulation (model 1 and model 2) can fit the increase and decrease in IL-10
levels. For a complete listing of the best fitting parameters, constraints and initial
conditions for each model, see Appendix A.3
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(a) (b)
(c) (d)
Figure 4.3.: (a) IL-10 protein (white dots) and il-10 mRNA (black dots) kinetics after stim-
ulation of macrophages with the immune modulator Av17. The experimental details can
be found in Figueiredo et al. (2009). (b-d) Fitted (lines) and experimental values (dots)
for IL-10 secreted protein (maximum value at 8 h) and il-10 mRNA (maximum value at 2
h). (a) Model 0: no feedback. (b) Model 1: inhibition of ERK phosphorylation via IL-10.
(c) Model 2: activation of ERK dephosphorylation via IL-10. The models fit the data for
both regulation hypotheses. Model 0 follows the production of IL-10, but cannot follow the
decrease, because there is no regulation, leading to cumulative production of IL-10, which
reaches a steady state.
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4.3. Model selection
The fitting results allowed to select models. The experimental data (Figure 4.3(a))
show that IL-10 production in macrophages after Av17 stimulation is transient. This
decrease in IL-10 production is an evidence for a regulation mechanism by negative
feedback. Therefore, I discarded model 0, which includes no regulation and presents
sustained IL-10 production. Moreover, the disagreement between fitted and experi-
mental values is very high (Figure 4.3). I calculated the Akaike Information Criterion
(AIC)1 and the residual sum of squares (RSS) between the estimated values and the
experimental data for the three models, and model 0 yielded the highest value (com-
pare Table 4.3). I discarded model 0 and focused on the models of regulation via IL-10
(model 1 and model 2). I compared the two different regulation mechanism that each
models implements, kinase inhibition (model 1) with phosphatase activation (model
2).
Model AIC RSS
0 -13.16 0.37
1 -31.44 0.15
2 -41.74 0.13
Table 4.3.: AIC and RSS for the three
models. Model 0 yields the highest value
and model 2 the lowest value.
1For details about this criterion, please refer to Section 2.1.3
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inhibition and phosphatase activation
Here I investigated the feedback properties that distinguish negative regulation by
kinase inhibition (model 1) and negative regulation by phosphatase activation (model
2).
According to Kholodenko (2006), phosphatases are homogeneously distributed in
the cytoplasm, whereas kinases are in the supra-molecular structures or in the cell
membrane. I assume that the regulation mechanism of the biological system can
switch from a kinase inhibition to a phosphatase activation mechanism, depending
on its position in the cell and the availability of kinases or phosphatases.
I changed the input level of Av17 and calculated the amplitude, integral, duration,
steady state and overshoot of the simulated IL-10 time course to understand how
kinase inhibition and phosphatase activation can be distinguished.
5.1. Level of the input stimulus controls the output signal
dynamics
The parasite load can vary within the host. Consequently, the concentration of
secreted Av17 may also vary. To check wether this disturbs the system performance,
I changed the concentration of Av17 (increasing and decreasing it) and examined how
this affects the behaviour of key components of each model. I implemented one-step
changes (from 0.1 to 70) and studied their effect on the dynamics of phospho-ERK
(Figure 5.5) and IL-10 (Figure 5.7) for kinase inhibition (model 1) and phosphatase
activation (model 2).
Phosphatase activation vs. kinase inhibition
Phosphatase activation has a linear activation and inhibition, whereas kinase inhi-
bition is non-linear, as Equations 5.1 and 5.2 describe and Figure 5.1 complements.
vk =
k ·m1p
1+ kf2 ·Xn (5.1)
vp = kf1 ·m1p ·Xn (5.2)
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Figure 5.1.: A phosphorylation/dephosphorylation cycle. (a) without feedback; (b) with
feedback inhibiting the kinase activity; (c) with feedback activating the phosphatase activity.
The feedback factor of the mechanism of phosphatase activation is Xn, whereas the
feedback factor of kinase inhibition is nonlinear and is 1/(1+ kf1 ·Xn). Figure 5.2
shows the feedback function for both cases. The kinase inhibition starts with the
value of one, when there is yet no IL-10. As IL-10 is being produced, the feedback
factor decays. When IL-10 reaches its maximum the feedback factor reaches its
minimum. The reverse happens with phosphatase activation. It has a positive and
linear relation to IL-10. This linearity is due to the fact that the exponent n, a free
parameter constrained between 1 and 10, was fitted to the value n = 1.1 (for details
about the value of each parameter, please consult Appendix A.3).
Figure 5.3 pictures how does ERK activation and deactivation relates to IL-10
production . Both models start with a null concentration of phospho-ERK and IL-10.
Model 1 has an immediate activation of phospho-ERK, which instantaneously reaches
its maximum. Phospho-ERK stays in a short plateau and decays with the shape of
a negative exponential, while IL-10 reaches its maximum (Figure 5.3 (a)). Model 2
has a linear activation and deactivation of ERK phosphorylation. Activation of ERK
phosphorylation is quite quick, but not instantaneous. When ERK phoshorylation
reaches its maximum, deactivation gets stronger than the activation and ERK goes
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Figure 5.2.: Graphic visualisation of the mathematical term responsible for the negative
feedback regulation. Blue line represents the feedback factor of kinase inhibition and red line
represents the feedback factor of phosphatase activation. X of equations 5.1 and 5.2 is IL-10.
The parameters k, kf1 and kf2 took the respective values assigned in model 1 and model 2.
immediately down. IL-10 keeps growing until its maximum and goes down to its
steady state. At this stage, phospho-ERK is already in steady state (Figure 5.3 (b)).
To better visualise the differences between regulation by phosphatase activation
and regulation by kinase inhibition, I plotted the feedback coefficient of each model,
i.e., I plotted the rates of phosphorylation and dephosphorylation of ERK (Figure
5.4).
Phospho-ERK
Changing the stimulus concentration, changes the amplitude of phospho-ERK. Phos-
pho-ERK of model 1 reaches maximal activation instantaneously and stays in a con-
stant amplitude value. This plateau is necessary to guarantee IL-10 production.
When the feedback kicks in, there is an instantaneous deactivation of phospho-ERK
(Figure 5.5(a)) and, consequently, of IL-10 (Figure 5.7(a)). The response to these in-
put variations in model 2 is different: first, phosphorylation levels go up linearly until
reaching maximal activation. At this point, the deactivation immediately happens
and is linear, i.e., the phosphorylation levels of ERK decrease as the input increases;
and second, the time point of maximal amplitude is reached sooner as the input
stimulus increases (Figure 5.5(b)). This slow, linear deactivation of phospho-ERK
has consequences at the level of IL-10 production.
The mechanism of kinase inhibition (model 1) assumes a cooperative behaviour
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Figure 5.3.: Difference between phosphatase activation and kinase inhibition. Parametric
plots of phospho-ERK versus IL-10 for (a) model 1 and (b) model 2. Please note the different
ERK phosphorylation levels (y-axis) between the models. ERK phosphorylation has its
maximum at 0.05 for model 1 and at 0.1 for model 2.
(a) (b)
Figure 5.4.: Dynamics of ERK phosphorylation/dephosphorylation for (a) model 1 and (b)
model 2. Blue curve: phosphorylation. Red curve: dephosphorylation
(Hill coefficient of 2.5). Therefore, the inhibition has a switch-like behaviour and be-
comes effective only with a certain delay, during which the phospho-ERK is maximally
active. When the feedback kicks in, there is a rapid deactivation of phospho-ERK
following the plateau of maximal activity (Figure 5.5(a)). In model 2, the negative
regulation by the increase in phosphatase activity is assumed to be a linear function
of IL-10. Therefore, the inhibition constantly increases, causing direct deactivation
after reaching the maximum (Figure 5.5(b)).
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(a) (b)
Figure 5.5.: Phospho-ERK kinetics for different input amplitudes (0.1 to 70). (a) Model 1.
(b) Model 2. Red line: input amplitude = 1
Phospho-p38
P38 activation is sustained for both models after increasing Av17 concentration. The
amplitude of phospho-p38 of both models increases until attaining saturation (2 arbi-
trary units (AU)), but as phospho-p38 activation is faster for model 1 than for model
2, the former reaches saturation faster than the latter (Figure 5.6).
(a) (b)
Figure 5.6.: Phospho-p38 kinetics for different input amplitudes (0.1 to 70). (a) Model 1.
(b) Model 2. Red line: input amplitude = 1
Extracellular IL-10 (IL-10)
Figure 5.7 shows how the different Av17 concentrations affect IL-10 dynamics. The
comparison of Figures 5.7(a) and 5.7(b) shows a shift in IL-10 behaviour. In terms
of signal amplitude, model 1 produces higher concentration of IL-10 than model 2.
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For both models, a decrease in Av17 concentration yields a concentration of IL-10
close to zero. This suggests that the macrophage starts producing IL-10 only after
a certain threshold of Av17 concentration is reached. When this threshold holds,
IL-10 production overshoots and goes down to a steady-state level. As the input
concentration increases, so does the maximum value of IL-10.
(a) (b)
Figure 5.7.: IL-10 kinetics for different input amplitudes (0.1 to 70). (a) Model 1. (b) Model
2. Red line: input amplitude = 1.
There is no significant difference between model 1 and model 2 for IL-10 rise time
(time to reach maximum production), but IL-10 downregulation is faster for the
former.
Negative regulation by kinase inhibition and negative regulation by phosphatase
activation have different outcomes for IL-10 dynamics. In terms of IL-10 produc-
tion and regulation, kinase inhibition is more effective than phosphatase activation.
This is because kinase inhibition produces produces more IL-10 than the model with
phosphatase activation, although the former phosphorylates less ERK than the latter
(Figure 5.5). Moreover, the regulation mechanism of kinase inhibition is more effec-
tive than the one of phosphatase activation, because kinase inhibition can reach a
steady state closer to the original steady state value (IL-10 steady state for Av17=1,
red line of Figure 5.7) than phosphatase activation.
Complex formation and transcription factor activation
According to Zhang et al. (2006), activated ERK phosphorylates the histone sites of
the il-10 promotor and activated p38 phosphorylates the transcription factors that
can bind to the open chromatin of il-10 promoter. In the present mathematical
models, I defined this process as a complex formation with three states:
• closed: Histone 3 (H3) site of IL-10 promotor is unphosphorylated and deacti-
vated (element X0);
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• open: H3 is phosphorylated (element X1);
• active: the activated transcription factor binds to the active H3 site and forms
a complex that leads to il-10 gene expression (element X2).
Figures 5.8, 5.9 and 5.10 illustrates the dynamics of the complex formation for
both models.
(a) (b)
Figure 5.8.: X0 kinetics for different input amplitudes (0.1 to 70). (a) Model 1. (b) Model
2. Red line: input amplitude = 1
(a) (b)
Figure 5.9.: X1 kinetics for different input amplitudes (0.1 to 70). (a) Model 1. (b) Model
2. Red line: input amplitude = 1
The three states of the complex formation are very similar for both models. How-
ever, it is important to notice that the amplitude of X2 is higher in model 2 than in
model 1 and that model 1 needs more time to reach maximal amplitude than model
2 in states X1 and X2.
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(a) (b)
Figure 5.10.: X2 kinetics for different input amplitudes (0.1 to 70). (a) Model 1. (b) Model
2. Red line: input amplitude = 1
I also compared the phosphorylation profiles of the transcription factors set, rep-
resented by A and Ap in the equation system 4.9. This is represented in Figure 5.11.
Interestingly, the phosphorylation of the transcription factors is very low in model
1. In model 2, A is totally transformed in Ap, i.e., the total amount of transcription
factors is phosphorylated.
5.2. The effects of phosphatase activation and kinase
inhibition on phospho-ERK and IL-10
To further characterise the differences between phosphatase activation and kinase
inhibition, I studied the characteristics of phospho-ERK and IL-10 using the following
concepts:
• Maximal amplitude (a): maximal concentration of the biological element under
study;
• Steady state (ss): point at which the dynamics of the element do not change
over time;
• Overshoot (o): the difference between maximal amplitude and steady state; it
yields the decay level of each element;
• Integral (i): total concentration of the biological element under study;
• Duration (w): the signal width at half of its maximal amplitude.
These concepts are represented in Figure 5.12.
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(a) (b)
(c) (d)
Figure 5.11.: Kinetics of A and Ap for different input amplitudes (0.1 to 70). A repre-
sents the unphosphorylated transcription factors, whereas Ap represents the phosphorylated
transcription factors. (a, b) Model 1. (c, d) Model 2. Red line: input amplitude = 1
Kinase inhibition is a more efficient amplifier than phosphatase activation
To infer the ERK phosphorylation levels and IL-10 concentration produced by this
biological system, I analysed the maximal amplitude and integral (Figures 5.13 and
5.14) for both models.
Figure 5.13 shows that kinase inhibition produces much higher levels of IL-10 than
phosphatase activation, in terms of its maximal concentration and total amount pro-
duced. This is in striking contrast with ERK phosphorylation levels. The system
with kinase inhibition cannot phosphorylate as much ERK as the system with phos-
phatase activation (Figure 5.14), but the former seems more efficient as an amplifier
than the latter. Indeed, a lower phosphorylation level of ERK relays a higher IL-10
concentration for a regulation by kinase inhibition than regulation by phosphatase
activation, in terms of maximal and total concentration level (comparing Figures 5.13
and 5.14).
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Figure 5.12.: Generic representation of the concepts of maximal amplitude (a), steady state
(ss), overshoot (o), integral (i) and duration, (w).
(a) (b)
Figure 5.13.: Comparison of model 1 (red) and model 2 (blue), in terms of IL-10 (a) maximal
amplitude and (b) integral
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(a) (b)
Figure 5.14.: Comparison of model 1 (red) and model 2 (blue), in terms of phospho-ERK (a)
maximal amplitude, (b) integral. The amplitude and total amount of ERK phosphorylation
have the same trend in both models, but model 2 phosphorylates more ERK than model 1.
(a) (b)
Figure 5.15.: Comparison of model 1 (red) and model 2 (blue), in terms of (a) phospho-ERK
and (b) IL-10 amplitude vs. integral.
These results are supported by Figure 5.15, where one can see that ERK phos-
phorylation levels are lower for kinase inhibition than for phosphatase activation,
but IL-10 production is much higher in terms of integral and maximal amplitude for
kinase inhibition than for phosphatase activation.
This renders the mechanism of regulation by kinase inhibition more efficient as an
amplifier than the regulation mechanism of phosphatase activation.
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IL-10 adaptation is stronger for kinase inhibition than for phosphatase
activation
Kinase inhibition can adapt faster than phosphatase activation, which is explained by
a stronger non-linear Hill coefficient in the feedback mechanism of kinase inhibition.
(a) (b)
Figure 5.16.: Comparison of model 1 (red) and model 2 (blue), in terms of IL-10 (a) steady
state, (b) overshoot. IL-10 steady state was measured at t=80 h.
In terms of IL-10, Figure 5.16 (a) shows that both models converge to a similar
steady state value. But the difference between the maximal amplitude and the steady
state (overshoot) is much higher for model 1 than for model 2 (Figure 5.16 (b)). The
fact that the maximal amplitude of IL-10 is higher in model 1 than in model 2 and that
model 1 reaches a lower and constant steady state in spite of input variations (Figure
5.13 (a)), explains the higher overshoot levels of model 1 and suggests that regulation
by kinase inhibition adapts better to a low steady state level than regulation by
phosphatase activation. On the contrary, Figure 5.17(a) shows that phospho-ERK
steady state for model 2 keeps increasing with input increases (although in a very low
level) whereas for model 1, there are no significant changes in the steady state level, in
spite of the input changes. This, together with the fact that model 2 phosphorylates
more ERK than model 1, is then reflected in a similar overshoot trend for model 1
and model 2.
These results indicate that kinase inhibition is a more effective way of producing
high levels of IL-10 for the same input value than phosphatase activation, because the
former regulation mechanism produces more IL-10 with less ERK phosphorylation
and has a better adaptation mechanism than the latter. This may render kinases a
more attractive regulation mechanism, in terms of total signal and adaptation to a
steady state level.
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(a) (b)
Figure 5.17.: Comparison of model 1 (red) and model 2 (blue), in terms of phospho-ERK (a)
steady state, (b) overshoot. phospho-ERK steady state was measured at t=4 h.
(a) (b)
Figure 5.18.: Comparison of model 1 (red) and model 2 (blue) in terms of signal duration for
(a) IL-10 and (b) phospho-ERK
Phosphatase activation is more efficient limiting IL-10 duration than
kinase inhibition
Measuring the signal width at half amplitude is a way of effectively quantifying the
signal duration. Figure 5.18 compares both models in terms of phospho-ERK and
IL-10 duration at half amplitude.
Interestingly, in terms of IL-10 production, the model with a phosphatase activation
mechanism lasts longer than the model with kinase inhibition, although the latter
produces much higher levels of IL-10 than the former.
In terms of ERK phosphorylation, model 1 has a longer duration than model
2. Nevertheless, the behaviour of both models is quite similar in terms of input
dynamics: as the input concentration changes, the signal duration decreases, reaching
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both a steady state around the same input concentration.
When the feedback with kinase inhibition kicks in, the concentration of IL-10 goes
down steeply, due to the non-linearity of this feedback. In the case of phosphatase
activation, the decrease of IL-10 concentration happens slower and in a linear fashion,
explaining why the duration of IL-10 is higher in this case than in the case of kinase
inhibition.
As expected, phospho-ERK can adapt better in the model of kinase inhibition than
in the model of phosphatase activation. Phospho-ERK steady state grows with the
input amplification for phosphatase activation feedback, whereas in kinase inhibition
the steady state value of phospho-ERK does not change in spite of changes in the
input. Nevertheless, the relationship between ERK amplitude and duration is similar
for both models (Figure 5.19(a) and (b)). In contrast, IL-10 duration keeps constant
when the amplitude increased in the case of regulation by kinase inhibition. In the
case of regulation by phosphatase activation, as the amplitude increases, the signal
duration goes down and up again (Figure 5.20(a) and (b)).
(a) (b)
Figure 5.19.: Comparison of duration with amplitude and integral for model 1 (red) and
model 2 (blue), in terms of phospho-ERK (a) and (c) and IL-10 (b) and (d).
In biological terms, negative regulation by kinase inhibition can be more effective
in terms of ensuring a high overshoot activation with low final steady state and a
high amount of IL-10. Negative regulation by phosphatase activation, in turn, can
be more effective to limit signal duration.
46
5.2. Characterisation of phospho-ERK and IL-10
(a) (b)
Figure 5.20.: Comparison of duration with amplitude and integral for model 1 (red) and
model 2 (blue), in terms of phospho-ERK (a) and (c) and IL-10 (b) and (d).
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6. Sensitivity analysis suggests an
autocrine crosstalk between ERK, P38
and IL-10
I performed a sensitivity analysis in order to understand how perturbations in the
system affect the output (IL-10 production). Therefore, I perturbed each parameter
of each model in a systematic manner and checked their influence on phospho-ERK,
phospho-p38 and IL-10 protein, in terms of steady state. The sensitivities were
calculated using the formula 2.18.
I imposed perturbations of 0.1 and 10 on each of these parameters. A perturba-
tion factor of 0.1 translates into the chemical inhibition of phosphorylation of one
of the MAPKs and a perturbation factor of 10 translates into the increase of the
phosphorylation levels of one of the MAPKs.
Tables 6.1 and 6.2 show the calculated sensitivities for model 1 and model 2,
respectively. These are the sensitivities of each parameter when perturbations at the
steady state level of ERK, p38 and IL-10 protein are imposed.
Model 1 and model 2 have different behaviours. Nevertheless, h is the most sensi-
tive parameter of both models. This parameter determines the feedback strength of
the models.
6.1. Model 1: phospho-ERK affects IL-10 production
Figure 6.1 shows the variations of parameter k1 of model 1. The perturbations
imposed to phospho-ERK affect its duration and amplitude (Figure 6.1(a)). As the
perturbation increases, the amplitude of phospho-ERK increases and the duration
decreases. These same perturbations also affect the amplitude and the duration of
il-10 mRNA (Figure 6.1(b)) and IL-10 protein (Figure 6.1(c)). The steady state
of IL-10 protein is also affected, but not the steady state of il-10 mRNA. These
perturbations have no direct effect on p38, phospho-p38 maintaining its curve over
the whole perturbation range (Figure 6.1(d)).
6.2. Model 1: phospho-p38 affects phospho-ERK and IL-10
production
I perturbed the phosphorylation rate constant of p38, k3 (Figure 6.2) and observed
that p38 activity, although not directly affected by the negative feedback, has an
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Model 1
k ERK P38 IL-10
0.1 10 0.1 10 0.1 10
k1 0.56 0.1 0 ∼0 0.56 0.1
k2 -0.99 -0.05 ∼0 ∼0 -1.04 -0.05
k3 -3.55 -0.06 0.97 0.24 0.51 0.04
k4 0.62 0.35 -2.48 -0.09 -0.43 -0.05
k5 -4.35 -0.08 ∼0 ∼0 0.55 0.1
k6 0.87 0.43 ∼0 ∼0 -0.96 -0.05
k7 -4.38 -0.08 ∼0 ∼0 0.56 0.1
k8 1.04 0.43 ∼0 ∼0 -2.2 -0.05
k9 0.96 0.43 ∼0 ∼0 -1.39 -0.05
k10 -4.38 -0.09 ∼0 ∼0 0.56 0.11
k11 -4.39 -0.09 ∼0 ∼0 0.56 0.1
k12 1.08 0.43 ∼0 ∼0 -3.51 -0.05
k13 -4.39 -0.09 ∼0 ∼0 0.56 0.1
k14 0.89 0.43 ∼0 ∼0 -1 -0.05
kf -0.99 -0.05 ∼0 ∼0 -0.99 -0.05
h -89410.2 0.05 -1699.66 ∼0 1.11 0.06
Table 6.1.: Sensitivities of ERK, p38 and IL-10 protein to perturbations of a factor of 0.1
or a factor of 10, on each parameter of model 1. k is the perturbed parameter. The Hill
coefficient, h, is the most sensitive parameter.
indirect impact on the feedback mechanism by influencing the production of IL-
10 and, consequently, ERK activity. This reveals autocrine feedback between the
MAPKs.
In this model, secreted IL-10 binds to the macrophage and promotes the dephos-
phorylation of phospho-ERK, establishing in this way a negative feedback mechanism.
Hence, the production of IL-10 interferes with the ERK signalling pathway, higher
IL-10 production reflecting higher feedback strength and lower duration of phospho-
ERK (Figures 6.2(c), 6.2(d)). By comparing both perturbations on parameters k1
for phospho-ERK and k3 for phospho-p38, I can observe that phospho-ERK has a
stronger influence on il-10 mRNA and IL-10 protein amplitude and that phospho-p38
exerts control over the feedback mechanism strength.
6.3. Model 2: phospho-ERK affects IL-10 production
I perturbed ERK activation by factors of 0.1 and 10 (Figure 6.3) and, as in the previ-
ous case, I see that perturbations of ERK do not affect p38 activation (Figure 6.3(d)).
They affect IL-10 production at the protein and mRNA levels in terms of amplitude
and duration, but only IL-10 protein in terms of steady state, similarly to model 1
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Model 2
k ERK P38 IL-10
0.1 10 0.1 10 0.1 10
k1 0.73 0.22 ∼0 ∼0 0.74 0.22
k2 -2.24 -0.07 ∼0 ∼0 -2.19 -0.07
k3 -0.01 ∼0 0.16 ∼0 0.01 ∼0
k4 ∼0 ∼0 -0.01 -0.01 ∼0 ∼0
k5 -0.01 ∼0 ∼0 ∼0 0.01 ∼0
k6 ∼0 ∼0 ∼0 ∼0 ∼0 ∼0
k7 -2.61 -0.07 ∼0 ∼0 0.74 0.22
k8 0.94 0.26 ∼0 ∼0 -5.11 -0.07
k9 0.93 0.26 ∼0 ∼0 -4.79 -0.07
k10 -2.62 -0.08 ∼0 ∼0 0.74 0.38
k11 -2.61 -0.07 ∼0 ∼0 0.74 0.22
k12 0.95 0.26 ∼0 ∼0 -5.65 -0.07
k13 -2.61 -0.07 ∼0 ∼0 0.74 0.22
k14 0.77 0.26 ∼0 ∼0 -2.18 -0.07
h -7866.78 -32.18 -38.43 0.85 1.11 145.61
Table 6.2.: Sensitivities of ERK, p38 and IL-10 protein to perturbations of a factor of 0.1
or a factor of 10, on each parameter of model 1. k is the perturbed parameter. The power
factor, h, is the most sensitive parameter.
(Figures 6.3(b) and 6.3(c)). ERK activation is also affected by its perturbations, in
terms of amplitude and duration, but not its steady state (Figure 6.3(a)).
6.4. Model 2: phospho-p38 affects phospho-ERK but has no
influence on IL-10 production
p38 perturbations affect ERK activation (as in model 1) due to the feedback mech-
anism. A high perturbation reflects high feedback strength, as observed by a lower
amplitude and duration of phospho-ERK (Figure 6.4(a)). IL-10 protein and mRNA
are not affected in terms of steady state and duration. The curves for no perturbation
and a perturbation factor of 10 are identical. This might be due to a possible satu-
ration effect. For a perturbation factor of 0.1, the amplitude is lower (Figure 6.4(b),
6.4(c)). Finally, Figure 6.4(d) shows that p38 activation is faster with increasing
perturbation factor.
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(a) (b)
(c) (d)
Figure 6.1.: Perturbations of phospho-ERK (model 1). Range of perturbation: factor 10 and
factor 0.1. Red line: no perturbation. Green line: perturbation factor is 0.1. Blue line: per-
turbation factor is 10. (a) Phospho-ERK: phospho-ERK affects its duration and amplitude,
but not steady state. (b) il-10 mRNA: perturbations affect its amplitude and the duration
but not the steady state. (c) IL-10 protein: perturbations affect its amplitude, duration and
steady state. (d) Phospho-p38 is not affected at all by phospho-ERK perturbations.
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(a) (b)
(c) (d)
Figure 6.2.: Perturbations of phospho-p38 (model 1). Range of perturbation: factor 10 and
factor 0.1. Red line: no perturbation. Green line: factor of perturbation is 0.1. Blue line:
factor of perturbation is 10. (a) Phospho-p38: perturbing phospho-p38 affects its amplitude.
(b) Phospho-ERK: phospho-ERK is sensitive to phospho-p38 perturbations, owing to the
feedback mechanism. Its amplitude maintains a constant level, its duration increases as the
perturbation decreases, and for a perturbation factor of 0.1, its steady state increases. (c)
il-10 mRNA: amplitude and duration are sensitive to perturbations of phospho-p38, but not
the steady state. (d) IL-10 protein: amplitude, duration and steady state are sensitive to
perturbations of phospho-p38.
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Figure 6.3.: Perturbations of phospho-ERK (model 2). Range of perturbation: factor 10 and
factor 0.1. Red line: no perturbation. Green line: factor of perturbation is 0.1. Blue line: fac-
tor of perturbation is 10. (a) Phospho-ERK: perturbing phospho-ERK affects its amplitude,
but not duration or steady state. (b) il-10 mRNA: perturbations affect its amplitude and du-
ration, but not steady state. (c) IL-10 protein: perturbations affect its amplitude, duration,
and steady state. (d) Phospho-p38 is not affected at all by phospho-ERK perturbations.
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6.4. Model 2: phospho-p38 affects phospho-ERK
(a) (b)
(c) (d)
Figure 6.4.: Perturbations of phospho-p38 (model 2). Range of perturbation: factor 10 and
factor 0.1. Red line: no perturbation. Green line: factor of perturbation is 0.1. Blue line: fac-
tor of perturbation is 10. (a) Phospho-ERK: perturbing phospho-p38 affects phospho-ERK
amplitude and duration but not steady state. (b) il-10m is insensitive except for a perturba-
tion factor of 0.1, which shows a decrease in amplitude. (c) IL-10 protein: shows the same
behaviour as il-10 mRNA. (d) Phospho-p38: phospho-p38 is sensitive to its perturbations
in terms of activation (its activation is faster as the interference increases) and in terms of
amplitude in a linear manner.
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7. Discussion of Part I
Parasitic nematodes modulate the immune response of their hosts by inducing IL-10
expression. In this part of my thesis, I modelled IL-10 production and regulation
in Av17 stimulated macrophages. I assumed that the production and regulation of
IL-10 happens via the MAPKs ERK and p38. Experimental data on IL-10 kinetics,
show that there is a regulatory mechanism dampening IL-10 concentration until a
low, constant basal level is reached. This motivated the design of models with two
different negative feedback mechanisms and one without feedback. I fitted them to
the observed time course for il-10 mRNA and IL-10 protein quantities.
The models assume that IL-10 protein, secreted from the macrophage, binds to the
same cell through the IL-10 receptor and deactivates ERK either by kinase inhibition
(model 1) or by phosphatase activation (model 2). Literature suggests that kinases
are localised in supra-molecular structures or in the cell membrane, whereas phos-
phatases are homogeneously distributed in the cytoplasm (Kholodenko, 2006). This
prompted me to study the difference between choosing a phosphatase or a kinase to
start the feedback mechanism.
Model 1 and model 2 suggest a transient activation of ERK and a sustained acti-
vation of p38.
First, I analysed the dynamics of ERK and p38. Both models suggest transient
ERK and sustained p38 activation. According to Yang et al. (2007), bone marrow
macrophages exposed to immune complexes and Leishmania mexicana present tran-
sient ERK and sustained p38 activation. Other authors suggest that the transient
kinetics of ERK could be due to internalisation and degradation of the growth factor
receptor (Sasagawa et al., 2005), a scenario not considered in this work. Following
the biological fact that the parasitic nematode A. viteae secretes Av17 in a con-
stant fashion (Hartmann et al., 1997), these models assume constant stimulation of
macrophages with Av17. In a more systemic view, the feedback effect could have
implications for the macrophage fate (activation/deactivation and differentiation).
Av17 binds to the macrophages and induces IL-10 production (Hartmann and Lu-
cius, 2003), and IL-10 deactivates macrophage function (O’Garra et al., 2008). I
hypothesised that this deactivation is achieved by the regulation of ERK via IL-
10. Other studies have shown that sustained activation of ERK on macrophage-
colony-stimulating-factor (M-CSF) mediated macrophages leads to differentiation
(Suzu et al., 2007). In mammalian PC12 cells, different ERK dynamics have dif-
ferent infuences in the cell fate (Marshall, 1995; Santos et al., 2007; Sasagawa et al.,
2005). This raises the question of whether different ERK dynamics have a different
impact in the fate of Av17-exposed macrophages.
Second, I modified the input concentration (Av17) and checked key features of
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ERK, p38 and IL-10 to understand the differences between phosphatase activation
and kinase inhibition. I checked the signal amplitude, duration, integral, steady
state and overshoot. The results indicate that activation of phosphatases (model
2) is a more efficient negative feedback mechanism for controlling signal duration
than inhibition of kinases (model 1). This can be explained by the fact more phos-
phatase accelerates dephosphorylation, whereas the dephosphorylation rate of the
kinase inhibition mechanism is constant. Interestingly, the inhibition of kinases is a
more efficient amplifier, in terms of signal maximal amplitude and integral, than the
activation of phosphatases. The ratio between IL-10 maximal amplitude and ERK
phosphorylation levels is much higher in model 1 than in model 2, indicating that
the model with kinase inhibition can produce more IL-10 with less phospho-ERK
than the model with phosphatase activation. Moreover, IL-10 overshoot indicates
that regulation through the inhibition of kinases presents better adaptation than
regulation through phosphatase activation. Model 1 can regulate IL-10 steady state
to a value much closer to IL-10 steady state without perturbations than model 2.
IL-10 steady state of model 2 is always approximately half of its maximal amplitude,
independently of different Av17 levels. Increasing input stimulation changes the du-
ration and the amplitude of ERK dynamics in both models. The dynamics of p38,
after increasing Av17 level, are sustained for both models and model 1 presents faster
activation than model 2. Hornberg et al. (2005a) have shown that phosphatases tend
to control signal duration and amplitude, which is in accordance with these results.
Av17 increases change IL-10 dynamics. IL-10 needs a certain minimum level of
Av17 to be produced and, as the concentration of Av17 in the present models in-
creased, the IL-10 concentration rose. However, the downregulation of IL-10 produc-
tion became less, and sustained production of IL-10 was achieved. The effect of high
levels of IL-10 production on the macrophage population in particular and on the
immune system in general is a question that remains unanswered.
Third, I performed a sensitivity analysis to study the effect that specific perturba-
tions in components of the system have on IL-10 production. Specifically, I perturbed
the parameter associated with ERK activation (k1) and checked the effect of this per-
turbation on p38 phosphorylation levels and IL-10 (mRNA and protein) levels. Then,
I perturbed the parameter associated with p38 activation (k3) and checked the effect
of this perturbation on ERK phosphorylation levels and IL-10 (mRNA and protein)
levels. Perturbing ERK activation has no effect on p38 activation but, interestingly,
perturbing p38 activation affects ERK activation. This revealed that ERK and p38
crosstalk through an autocrine feedback and that p38 has a prominent role on the
feedback mechanism that dampens IL-10 signal. Moreover, this analysis suggested
that k1) influences the amplitude, duration and steady state of IL-10 in model 1 and
model 2, whereas k3 has the same influence only in model 1. These perturbations in
model 2 revealed no change in IL-10 behaviour except for the perturbation factor of
0.1, affecting IL-10 amplitude.
Understanding the process behind IL-10 regulation and macrophage deactivation
could open the door to understanding the the role of ERK in macrophage fate. Av17
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and IL-10 deactivate macrophages and this could be a consequence of the transient
time course of ERK. According to Staples et al. (2007), IL-10 activates the JAK.STAT
signalling pathway when bound to macrophages, inducing IL-10 (protein and mRNA)
production on activated macrophages, but can also suppress il-10 mRNA production
in the same cells. Sánchez-Tilló et al. (2007) point out that IL-10 activates JNK1,
which in turn activates DUSP1 expression. As the lack of DUSP1 causes prolonged
ERK activation this would suggest that DUSP1 is a feedback mediator of IL-10
production.
Taken together, this part of my thesis proposes a mathematical model that suggests
how is IL-10 produced and regulated in macrophages exposed to immunomodulatory
molecules of parasitic nematodes. It suggests that:
• IL-10 is regulated in an autocrine fashion;
• Av17 activates ERK and P38;
• IL-10 production is dependent on ERK and P38 activation;
• the feedback mechanism of kinase inhibition is a better amplifier than phos-
phatase activation in terms of IL-10 maximal and total production;
• Phosphatase activation is more effective on limiting signal duration than kinase
inhibition;
• phospho-p38 affects ERK via secreted IL-10, indicating an autocrine crosstalk
between the two MAPKs.
A mathematical model goes hand in hand with experimental data. In order to vali-
date and refine the model, I propose the following experiments:
• measure the activity of MAPK phosphorylation;
• test the dose response of IL-10 protein and phospho-ERK to Av17 increases;
• inhibit the autocrine IL-10 signalling pathway with anti IL-10R antibodies and
measure IL-10 levels at different time points, as well as phospho-ERK and
phospho-p38 time series.
• test if the transcription factors CREB, SP1 and STAT3 are involved in IL-10
expression and, furthermore, if they are MAPK dependent.
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Part II.
Signalling events regulate IL-10
production in macrophages
stimulated with an
immunomodulator of parasitic
nematodes
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8. Synopsis
This work is partially published in Klotz et al. (2011), where the experimental proce-
dures can be found. The experiments here referred, were conducted by Christian Klotz
and Thomas Ziegler, from the Department of Parasitology, Humboldt-Universität zu
Berlin.
Here I combine a theoretical approach with experimental data to understand
the signalling events triggered by Av17 in macrophages. I applied mathematical
modelling to characterise signalling elements involved in the manipulation of the
macrophage. As suggested in the previous part, IL-10 expression in Av17 stimulated
macrophages was tyrosine kinase sensitive and dependent on activation of both ERK
and p38 MAP kinases. The fact that both kinases have transient dynamics, suggests
that there is a regulation mechanism acting at the signalling level to regulate IL-
10 production. To understand how this regulation happens, I hypothesised several
alternative ways of signalling regulation. I developed a method of model selection
that combines the theoretical predictions with experimental evidences to select a
valid model that can correctly predict the experimental data. This systems biology
approach allowed to grasp regulatory characteristics of the biological network, that
would have not been feasible solely by using an experimental approach.
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9. MAPK ERK and p38 are essential for
IL-10 production in Av17 stimulated
macrophages
Macrophages respond to external cues by activating specific signalling pathways. In
the previous part of this thesis, I suggested that Av17 activates the MAPK signalling
cascades ERK and p38 to induce IL-10 expression. In this part of my thesis, I com-
bined mathematical modelling with experimental data to understand which signalling
events induced by Av17, lead to IL-10 expression and regulation in macrophages.
9.1. Validation of model 1 and model 2
The involvement of ERK and p38 was experimentally tested and confirmed the hy-
pothesis raised by the model: Av17 activates ERK and p38 in macrophages and
IL-10 production depends on the parallel activation of both signalling cascades.
Figure 9.1.: IL-10 expression in Av17-stimulated macrophages in the presence of MAPK
inhibitors (a) MEK inhibitor, which inhibits the ERK signalling cascade (b) p38 inhibitor.
Both MAPKs are essential for IL-10 production in Av17-stimulated macrophages. The ex-
perimental details of this work can be found in Klotz et al. (2011).
Experimental testing of IL-10 expression was done using the specific inhibitors of
both MAPK kinases. Results show that ERK and p38 are both essential for IL-10
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9. ERK and p38 are essential for IL-10 production
(a)
(b) (c)
Figure 9.2.: ERK phosphorylation in Av17-stimulated macrophages. (a) Western blot of
ERK phosphorylation measured in Av17-stimulated macrophages. (b), (c) Prediction and
validation of ERK dynamics. Solid line: predicted phospho-ERK dynamics; dots: experi-
mental values for phospho-ERK. The experimental details of this work can be found in Klotz
et al. (2011).
production, according to the model hypothesis. Figure 9.1 shows the experiment
confirming this hypothesis.
Furthermore, the activation of both kinases is transient, as Figures 9.2(a) and 9.3(a)
illustrate. I validated model 1 and model 2 of Part I by comparing the experimental
results with the model predictions. Both models correctly predict the behaviour of
phospho-ERK, as represented in Figures 9.2(b) and 9.2(c).
Both models predict a sustained P38 activation, which is not observed experimen-
tally, as Figure 9.3 shows.
This motivated the design of a feedback mechanism acting both on ERK and p38.
In fact, these kinases activate specific phosphatases - by induction of gene expression
or by protein phosphorylation - which have the ability to dephosphorylate the same
kinases that activate them, revealing a negative feedback circuit (Blüthgen et al.,
2009; Patterson et al., 2009).
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9.1. Validation of model 1 and model 2
(a)
(b) (c)
Figure 9.3.: Prediction of P38 dynamics. Solid line: predicted phospho-p38 behaviour; dots:
experimental values for phospho-p38. (a) Model 1. (b) Model 2.
Other signalling molecules can also have an active role on the regulation of IL-
10 production. The activation of AKT was also tested and, despite the fact that its
specific inhibitor indicated a role for PI3K pathway in Av17 induced IL-10 production,
no specific phosphorylation of AKT was detectable after Av17 stimulation (Klotz
et al., 2011). This suggests that endogenous, physiological levels of phospho-AKT
suffice for optimal cytokine production in macrophages after Av17 stimulation.
Bringing these facts together with the hypothesis suggested in Part I, that IL-
10 regulates its own production, I propose three alternative regulation principles,
explained in the next chapter.
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10. Definition of alternative mechanisms
of IL-10 regulation
To understand how the MAPKs interact and regulate IL-10 expression and to ac-
commodate the new data, I adapted the mathematical model published in Figueiredo
et al. (2009) to incorporate a negative feedback mechanism acting at the MAPK level,
specifically on ERK and p38. Based on this, I constructed and tested various math-
ematical models and investigated their ability to predict the experimental findings.
I hypothesized three underlying regulating mechanisms:
1. IL-10 itself deactivates the MAPKs (Autocrine feedback);
2. Phosphatases such as DUSPs deactivate the MAPKs;
3. An independent molecule (IM) (i.e., a molecule not activated by Av17) deacti-
vates the MAPKs.
I conducted a systematic analysis of the biologically feasible combinations of these
mechanisms. A master model illustrates the scope of this analysis (Figure 10.1).
10.1. Construction of the mathematical models
This master mathematical model containing regulation reactions of interest was
implemented using ordinary differential equations (ODE) in the Systems Biology
Markup Language (SBML) format (Hucka et al., 2003).
Within the frame of this master model (Figure 10.1), 35 more specific models (each
representing a specific hypothesis about the underlying feedback mechanisms) were
generated and tested using the software tool for model generation and discrimination
ModelMaGe (Flöttmann et al., 2008) 1.
In order to reduce the number of possible combinations, I assumed that:
• DUSP acts only as one single phosphatase;
• IL-10 acts either as phosphatase or kinase, but never both at the same time;
• IM acts either as phosphatase or kinase, but never both at the same time.
1http://www.modelmage.org
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Figure 10.1.: Wiring scheme of the master model of IL-10 production and regula-
tion in macrophages after Av17 stimulation. This graphical model represents possible
IL-10 regulation mechanisms (regulation of IL-10 through DUSP, IL-10 or an independent
molecule (IM)) and comprises the possible mechanism of achieving this regulation. Green
lines represent the regulation reactions dependent on IM, blue lines represent the regulation
reactions dependent on DUSP and red lines represent the regulation reactions dependent on
IL-10. Black lines represent the reactions of the core model, which does not change indepen-
dent of the regulation mechanism.
70
10.1. Construction of the mathematical models
Table 10.1 lists the 35 alternative models.
Model Model design
1 ERK → DUSP a ERK and IL-10 a P38 KI
2 ERK → DUSP a ERK and IL-10 a P38 PA
3 ERK → DUSP a P38 and IL-10 a ERK KI
4 ERK → DUSP a P38 and IL-10 a ERK PA
5 ERK → DUSP a (P38 and ERK)
6 P38 → DUSP a P38 and IL-10 a ERK KI
7 P38 → DUSP a P38 and IL-10 a ERK PA
8 P38 → DUSP a ERK and IL-10 a P38 KI
9 P38 → DUSP a ERK and IL-10 a P38 PA
10 P38 → DUSP a (P38 and ERK)
11 (ERK and P38) → DUSP a ERK and IL-10 a P38 KI
12 (ERK and P38) → DUSP a ERK and IL-10 a P38 PA
13 (ERK and P38) → DUSP a P38 and IL-10 a ERK KI
14 (ERK and P38) → DUSP a P38 and IL-10 a ERK PA
15 (ERK and P38) → DUSP a (P38 and ERK)
16 IL-10 a (ERK and P38) KI
17 IL-10 a (ERK and P38) PA
18 IM a ERK KI and IL-10 a P38 KI
19 IM a ERK PA and IL-10 a P38 KI
20 IM a ERK KI and IL-10 a P38 PA
21 IM a ERK PA and IL-10 a P38 PA
22 IM a ERK KI and P38 → DUSP a P38
23 IM a ERK PA and P38 → DUSP a P38
24 IM a ERK KI and ERK → DUSP a P38
25 IM a ERK PA and ERK → DUSP a P38
26 IMa P38 KI and IL-10 a ERK KI
27 IM a P38 PA and IL-10 a ERK KI
28 IM a P38 KI and IL-10 aERK PA
29 IMa P38 PA and IL-10 a ERK PA
30 IM a P38 KI and ERK → DUSP a ERK
31 IMa P38 PA and ERK → DUSP a ERK
32 IM a P38 KI and P38 → DUSP a ERK
33 IMa P38 PA and P38 → DUSP a ERK
34 IM a (P38 and ERK) KI
35 IM a (P38 and ERK) PA
Table 10.1.: Mathematical models derived from the master model shown in Figure 10.1. IM:
independent molecule, KI: kinase inhibition, PA: phosphatase activation, →: activation, a :
inhibition.
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10.2. Model selection procedure
The workflow of Figure 10.2 illustrates the process of model selection described in
the following sections.
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Figure 10.2.: Work flow describing the process of model selection. 35 alternative models are generated based on literature and experi-
mental data, fitted to the available experimental data (ERK, p38, and IL-10) and ranked based on the AIC. The best model is selected
and checked if it predicts the experimental data. If not, the next best model is selected until having one that fits the data. If yes,
a dedicated experiment is done in order to test the specific method of regulation mechanism of the selected model. If the model is
consistent with this new experiment, then the model will be selected. (Adapted from Klotz et al. (2011)).73
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10.2.1. Model fitting
To span over a wide range of possible parameter sets, I fitted each model several times,
combining different data sets with different algorithms and parameter constraints. I
fitted each model to two different data sets. Data set 1 comprised the kinetic data
of IL-10 (mRNA and protein, Figure 4.3(a)) and half-life of il-10 mRNA (for the
half-life values, see Appendix A.2), together with p38 kinetics. Data set 2 comprised
the same kinetic data of IL-10 (mRNA and protein) and half-life of il-10 mRNA,
but together with ERK kinetics. Each model was fitted eight times to each data set,
using different algorithms and parameter ranges. I used global estimation methods
to fit the different models to the data. Details about global estimation methods can
be found in section 2.1.2. These were algorithms for Evolutionary Programming and
Simulated Annealing. I constrained the free parameters between 0.0001 and 10 or
0.0001 and 100. To fit the models to the data, I used the software COPASI (Hoops
et al., 2006).)
10.2.2. Model discrimination and selection strategy
Model discrimination was done with ModelMaGe (Flöttmann et al., 2008), using the
AIC. AIC yields a relative value that scores the model, where the lowest value is
the best score. (please refer to Burnham and Anderson (2002) and section 2.1.3). I
calculated the AIC for each model and each fitting method, obtaining 16 different
AIC values for each model. I then ranked the models (according to the lowest AIC)
for each fitting method. To select between models, I then computed how often each
model occurred among the“ top 10” lists. These lists can be consulted in appendix A,
section B. I selected the most frequently occurring model and checked its consistency
with the experimental data by comparing its predictions of ERK or p38 kinetics with
the respective experimental values.
Validation and falsification of the first model This model, 17 of table 10.1, in-
cluded an IL-10 dependent mechanism of the transient MAPK activation and IL-10
regulation seen in macrophages after Av17 treatment. To simplify the mathematical
model I assumed that IL-10 could directly act on ERK and/or p38, whereas in reality
a feedback would involve surface-located IL-10 receptors. In order to verify assump-
tion 1, that IL-10 itself regulates the MAPKs expression (autocrine feedback), the
IL-10 receptor was experimentally blocked applying anti-IL-10 receptor antibodies
(anti-IL-10R ab) and the level of IL-10 expression in macrophages after Av17 treat-
ment was compared 2 (Figure 10.3). No effect was seen on IL-10 regulation (18h and
24h) in the absence of IL-10 receptor signalling, thus excluding a feedback mechanism
by IL-10 itself.
Selection of the next best model In response to this result, I searched, in the top 10
frequency list, for the models that did not include a feedback mechanism through IL-
2Experiment performed in the Department of Parasitology, Humboldt-Universität zu Berlin
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(a) (b)
Figure 10.3.: (a) IL-10 expression in macrophages stimulated with Av17 and anti-IL-10R ab
at several time points. (b) IL-10 expression in Av17 stimulated macrophages from il-10−/−
mice. Black bars correspond to wild type (wt) mice and white bars correspond to il-10−/−
mice. At the level of IL-10 regulation, there is no significance difference between IL-10
expression in Av17 stimulated macrophages and the same cells with Av17 and anti-IL-10R ab
or in il-10−/− mice. These results indicate that IL-10 does not play a role on the regulation
of itself. AvCys corresponds to Av17. The materials and methods of this experiment can be
found in Appendix A.4.
10. These were model 15 and model 25. To distinguish both, I calculated the average
of the AIC and I created again an ordered list with the best 10 models. Model 15 was
the top ranked model which did not include an IL-10 feedback mechanism. To check
for the robustness of this selection method, I computed the median of the AIC and
created a list with the top 10 ranked models. Again, model 15 was the best ranked
model without an IL-10 feedback mechanism. Figure 10.4 shows the Venn diagram
of the three “top 10” sets.
The model The selected model (model 15 of Table 10.1) assumed activation of p38
and ERK leading to DUSP expression that in turn negatively regulates both ERK
and p38 (Figure 10.5). The model assumes only one variable for the activated DUSPs
as a first approximation to the biological system.
Figures 10.6 illustrate how the model fits to the experimental data, showing that
this model mimics the experimental findings.
I further compared the model predictions and experimental data for phospho-ERK
and found a similar trend for ERK dynamics 10.7. The selected model predicts a
peak of ERK dynamics at time point t=0.8 h and this is supported by the experimen-
tal data. The model curve for phospho-ERK has a faster decay than experimental
phospho-ERK.
To understand the differences between in silico and in vitro phospho-ERK dynam-
ics, I searched for another parameter set that could predict ERK phosphorylation
with similar dynamics to the experimental data. I also reduced the model by supress-
ing il-10 and dusp mRNA transcription steps. In both cases, I found a parameter
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Figure 10.4.: Venn diagram of the three different top 10 sets. The green set corresponds to
the “top 10” rated frequencies; the red set corresponds to the “Top 10” average and the blue
set is the “top 10” median. Model 15 is the only model that intersects the three sets and
does not include a regulation mechanism through IL-10. Models written in gray/italics were
excluded after the dedicated experiment testing if IL-10 was responsible for the regulation
mechanism.
set that predicted the ERK dynamics with a lower error than the phospho-ERK pre-
diction of Figure 10.7. Then, to select the best model out of these three versions, I
did a robustness analysis by randomly perturbing the input and analysing the effect
of these perturbations on the IL-10 steady state level (please refer to section 14 for
details about the method). The analysis shows that the first parameter set of model
15 is more robust than the remainder model versions Therefore, I selected model 15
as the model that best represents this biological system, in spite of the fact that it
cannot perfectly mimic phospho-ERK in vitro behaviour.
Additionally, the behaviour of DUSP gene expression was predicted and experi-
mentally confirmed. I resume the procedure in the following steps:
• Implement 35 alternative models that account for different regulation mecha-
nisms of IL-10 regulation;
• Systematically fit and test these models;
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Figure 10.5.: Graphical representation of model 15 of Table 10.1.
• Model selection based on the AIC indicated a model with regulation through
IL-10;
• Experimental testing of IL-10 kinetics when IL-10 blocking antibodies are add-
ed, suggests that IL-10 does not play a role in regulating the MAPKs;
• A model that includes DUSP as a regulator of ERK and P38 is selected;
• Experimental testing of DUSP suggests that DUSP1 and DUSP2 are present
after Av17 stimulation and supports the selected mathematical model.
Taken together, the mathematical model hypothesises that DUSPs implement a
negative feedback mechanism acting on p38 and ERK.
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(a) (b)
Figure 10.6.: Fitted (lines) and experimental values (dots) for (a) IL-10 secreted protein and
il-10 mRNA (maximum value at 2 h). (b) phospho P38
Figure 10.7.: Prediction of phospho-ERK dynamics. Line: simulated dynamics. Dots: ex-
perimental data points
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11. Testing the model with further
experimental data
11.1. Av17 induced differential expression of DUSPs
The selected model predicted a time dependent expression of dusp mRNA, having
its maximum at time point t=1.7 h. To validate the predicted role of dusps, the
kinetics of the mRNA expression of several dusp was experimentally tested after Av17
treatment. The tested phosphatases have all been associated with the regulation of
activated MAP kinases (Liu et al., 2007). The expression of dusp1 and dusp2 mRNA
was observed at 30 Min in Av17 stimulated macrophages. dusp1 expression had the
maximum peak at 60 Min and dusp2 expression was constant between 30-240 Min
after Av17 stimulation. There was a slight increase in the expression of dusp5 mRNA
between 30-120 Min. The mRNA levels of dusp3, dusp6 and dusp10 were not altered
in Av17 treated macrophages, as Figure 11.1 pictures.
This data support the selected mathematical model and suggest that DUSP1 and
DUSP2 are relevant for Av17 modulation of macrophages, since both have been de-
scribed as targets and regulators of p38 and ERK (Jeffrey et al., 2006; Chi et al.,
2006; Anderson and Mosser, 2002b). Moreover, a preliminary microarray data anal-
ysis suggests the presence of different dusps in Av17 stimulated macrophages. Please
refer to Appendix C for details. I plotted the in vitro expression of dusp1 and dusp2
mRNA and in silico prediction of dusp mRNA in one graph and found that the model
showed a similar trend of the expression curves and a slightly delayed expression pat-
tern compared to experimental expression of dusp1 and dusp2 mRNA (Figure 11.2).
The predicted dusp mRNA kinetics of the mathematical model reflects dusp1 mRNA
expression better than dusp2, indicating that dusp1 might be more important in reg-
ulating this biological system. Moreover, a phosphorylation of DUSP1 has also been
observed 11.1(B).
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Figure 11.1.: Expression of dusp1 and dusp2 in macrophages by Av17. (A) Real time PCR
analysis of the mRNA levels of dusp1, dusp2, dusp3, dusp5, dusp6 and dusp10. (B) Western
blot using antibodies against phospho-DUSP1 and DUSP1, respectively, and beta-actin. The
experimental procedures of these experiments can be found in Klotz et al. (2011).
Figure 11.2.: Mapping the experimental data from dusp1 and dusp2 with predicted dusp
mRNA. The values of dusp1 and dusp2 mRNA were converted to arbitrary units and overlay
with predicted dusp mRNA from model 15. Line: simulated dynamics. Dots: experimental
data points.
11.2. dusp1 regulates IL-10 expression in macrophages
To further investigate the role of DUSPs, IL-10 expression and MAPK activation af-
ter Av17 treatment in macrophages from dusp1−/− mice were analysed (Klotz et al.,
2011). Macrophages from wild type (wt) mice showed a transient il-10 mRNA ex-
pression after Av17 treatment, whereas dusp1−/− macrophages showed a sustained
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11.3. in-vivo dusp measurements are closer to model predictions
and increased IL-10 expression, confirming an important role of DUSP1 in IL-10
regulation in macrophages following Av17 treatment. Av17 stimulated macrophages
from dusp1−/− mice showed high accumulation of phospho-p38 and slightly reduced
phospho-ERK levels as compared to macrophages from wild type animals (Figure
11.3). In conclusion, this data are in accordance to the model predictions and empha-
sised the importance of DUSP1 for the regulation of MAPK activation and cytokine
regulation in Av17 stimulated macrophages.
Figure 11.3.: (A,B) Macrophages from dusp1−/− mice and wt were treated with Av17 or the
same amount of denaturated Av17 as a control. (A) Real time PCR analysis was performed
for IL-10 and IL-12/23p40. (B) Western blot using antibodies against phospho-p38, phospho-
ERK and beta-actin. Normalised data are expressed as fold induction compared to untreated
controls. The experimental procedures of these experiments can be found in Klotz et al.
(2011)
The dissimilarities between the model and the experimental data seen in Figure
11.2 are possibly because different DUSPs have distinct functions and for that reason
their behaviour cannot be totally reflected by one representative DUSP in the model.
Nevertheless, the model correctly predicts an overall effect of DUSPs on MAPK
regulation.
11.3. in-vivo dusp measurements are closer to model
predictions
In vivo measurements are important to clarify the relevance of these findings. The
data revealed the induction of dusp1 and dusp2 mRNA expression, as well as IL-10
transient expression. I compared the DUSP in silico predictions with dusp1 and
dusp2 in vivo kinetics. Figure 11.4 shows the measurements of dusp1, dusp2 and
dusp5 in vivo.
Surprisingly, the model can more accurately predict the in vivo kinetics of dusp1
and dusp2 as of the in vitro kinetics, as Figure 11.5 shows.
Taken together, this data indicate that ERK and p38 activation in Av17 stimulated
macrophages activate DUSP1 and DUSP2 (mRNA and protein). DUSP1 and DUSP2
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Figure 11.4.: In vivo effect of Av17 in macrophages shows DUSP expression. Mice were
treated with Av17 or denaturated Av17 as a control for 1 h, 4 h or 18 h. This figure shows
the real time PCR analysis for (A) dusp1 and dusp2. Detailed experimental procedures of
these experiments can be found in Klotz et al. (2011)
Figure 11.5.: Mapping the in vivo data fromdusp1 and dusp2 with in silico DUSP. The values
of dusp1 and dusp2 mRNA were converted to arbitrary units and overlay with predicted
DUSP from model 15. Line: simulated dynamics. Dots: experimental data points.
are the feedback elements that regulate ERK and p38 activation and, consequently,
IL-10 (mRNA and protein) production. These findings were supported not only by
in vitro testing, but also by in vivo experiments.
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11.4. A sensitivity analysis revealed that DUSP mediates
crosstalk between individual MAPKs
The selected model proposes a wiring scheme that interconnects ERK and P38
through DUSP, and these components interact together in the regulation of IL-10
expression. Cross regulation is often observed between different elements of sig-
nal transduction networks. To determine possible crosstalk between ERK and p38
in Av17 stimulated macrophages and to understand the hierarchical steps of the
signalling cascades, I computed a sensitivity analysis. This analysis consisted on
studying how the perturbation of one species interferes with the activity of another,
while keeping the remaining species untouched. More specifically, I hypothesised
that DUSP mediates crosstalk between the individual MAPK components. To test
this hypothesis, I perturbed the phosphorylation rate of ERK and p38 individually
and I analysed the sensitivity (Equation 2.18) of p38, ERK, IL-10 protein and dusp
mRNA in terms of signal amplitude (concentration or phosphorylation rate of the
component) and the time it takes to reach signal maximum.
I used perturbation factors of 10 (reflecting increase) and 0.1 (reflecting decrease)
to evaluate the effect of a higher and lower phosphorylation rate of one of the MAPK
p38 and ERK, respectively, and compared them to the unperturbed values.
I compared the results of these sensitivity analysis with experimental data on the
phosphorylation levels of ERK and p38 in the presence of specific inhibitors. These
experimental results are in total agreement with the in silico sensitivity analysis.
Perturbations in the phosphorylation rate of ERK produced no effect on p38
11.6(d). In contrast, a higher or a lower phosphorylation rate of p38 produced a
decreasing or an increasing effect on ERK phosphorylation rate (Figure 11.6(a)).
Experimental testing of phospho-ERK in the presence of p38 inhibitor and Av17,
yielded approximately 50% stronger ERK phosphorylation levels compared to the
ERK stimulation by Av17 only, indicating a negative regulatory effect of p38 on ERK
phosphorylation. Interestingly, the inhibition of ERK phosphorylation did not affect
the phosphorylation levels of p38 in Av17 stimulated macrophages (Figure 11.7).
Hence, the experimental data together with the mathematical model, suggested an
autocrine crosstalk of p38 acting on ERK.
Next, I checked the influence of ERK or p38 on il-10 gene expression. The sen-
sitivity analysis showed that a perturbation of the ERK phosphorylation rate had
a strong and linear effect on il-10 expression level (Figure 11.8(a)). Inhibition of
p38 phosphorylation levels resulted in the inhibition of IL-10 amplitude and a total
inhibition of phospho-p38 completely blocked il-10 expression. The experimental
data, published in Klotz et al. (2011), further confirmed the model. Amplification of
p38 phosphorylation levels did not affect IL-10 expression (Figure 11.8(b)). This can
be explained by a possible saturation effect. Perturbations of both MAPK elements
showed no significant variations on IL-10 signal build up time (Figures 11.8(a) and
11.8(b)) These results suggest that, although p38 also affects IL-10 expression levels,
ERK phosphorylation is dominant in determining the level of the IL-10 expression.
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(a) (b)
(c) (d)
Figure 11.6.: The effect of ERK perturbations on p38 activation (a) and the effect of p38
perturbations on ERK activation (b). Range of perturbation: factor 10 and factor 0.1.
Red line: no perturbation. Green line: factor of perturbation is 0.1. Blue line: factor of
perturbation is 10. (a) perturbations in the phosphorylation rate of ERK produced no effect
on p38 (b) higher/lower phosphorylation rate of p38 produced a decrease/increase on ERK
phosphorylation rate (signal amplitude) and an increase/decrease in signal build up time
Interestingly, ERK perturbations did not affect DUSP (Figure 11.9(a)). In con-
trast, perturbations of p38 phosphorylation rate produced a linear effect on DUSP
expression (Figure 11.9(b)).
Overall, the mathematical and experimental evidences showed that ERK affects
mainly IL-10 production and regulation, whereas p38 affects mainly IL-10 and DUSP
activation. Moreover, phospho-p38 inhibits the strength of ERK phosphorylation
through an autocrine crosstalk.
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Av17 Av17
Figure 11.7.: Av17 stimulated macrophages were treated with p38 (first column) or MEK1/2
inhibitor (second column). After indicated times total cell extracts were isolated and analysed
by western blot. Densitometric analysis of (a) phospho-ERK and (b) phospho-p38. Phospho-
ERK and phospho-p38 signals (y-axis) are represented in percentual terms. A level of 100%
means that there is no difference between the experiment with the inhibitor and its respective
control. Levels between 0% and 100%, reflect inhibition of phosphorylation; levels above 100%
reflect increase of phosphorylation. Experimental details in Klotz et al. (2011).
(a) (b)
Figure 11.8.: Perturbations of ERK and P38 activation on IL-10. Range of perturbation:
factor 10 and factor 0.1. Red line: no perturbation. Green line: factor of perturbation is
0.1. Blue line: factor of perturbation is 10. (a) ERK phosphorylation rate had a strong and
linear effect on IL-10 protein levels (b) perturbation of p38 phosphorylation rate had only a
minor effect on the IL-10 amplitude.
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(a) (b)
Figure 11.9.: Perturbations of ERK and P38 activation on DUSP. Range of perturbation:
factor 10 and factor 0.1. Red line: no perturbation. Green line: factor of perturbation is
0.1. Blue line: factor of perturbation is 10. (a) perturbations of ERK phosphorylation rate
did not affect DUSP (b) a higher/lower phosphorylation rate of p38 decreases/increases the
signal build up time and increases/decreases the amplitude of DUSP mRNA expression.
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12. Discussion of Part II
In this part of my thesis, I used a systems biology approach to clarify which pathways
lead to IL-10 regulation in macrophages after Av17 stimulation. This work was
done in cooperation with the Department of Parasitology, Humboldt-Universität zu
Berlin. The mathematical models developed in Figueiredo et al. (2009) and presented
in chapter 4.1, hypothesised that Av17 activates the signalling cascades ERK and
p38 in parallel, and that both signalling cascades are essential for IL-10 production.
Experimental testing of these pathways validated the model hypothesis. However,
the transient behaviour of these MAPKs suggested a regulation mechanisms acting
on both ERK and p38. Therefore, I adapted the original mathematical model to
include regulation mechanisms acting both on ERK and p38. I suggested that IL-
10 regulation happens at the signalling level and that there are 3 different ways to
achieve it:
1. IL-10 itself deactivates the MAPKs expression;
2. Phosphatases such as dusps deactivate the MAPKs;
3. An independent molecule (i.e., a molecule not activated by Av17) deactivates
the MAPKs.
Modelling and experiments suggested that this activation is regulated by a feedback
mechanism involving dusps.
Regulation by negative feedback mechanisms control intracellular events stimulated
extracellularly. When there is activation of MAPKs, phosphatases such as DUSPs
are the main characters of these control mechanisms (Jeffrey et al., 2007; Liu et al.,
2007; Blüthgen et al., 2009). The selected mathematical model predicted that DUSPs
regulate IL-10 production and this was validated by dedicated experiments. Av17
induced the expression of dusp1, dusp2 in vitro and in vivo. Moreover, in dusp1−/−
mice, IL-10 expression is sustained and p38 phosphorylation is stronger than in wt
mice, revealing the essential role of dusp1 on IL-10 regulation (Klotz et al., 2011).
The selected model was able to correctly predict the biological data. Consequently, I
used this model to further analyse the biological network, doing in silico experiments
more difficult to undergo in vivo or in vitro.
For this, a systems biology approach enabled the study of interconnections between
the elements that compose the molecular network. I perturbed single components
of the system (while keeping the remaining constant) and observed the behaviour of
other components. Specifically, I disturbed ERK or p38 and checked the influence of
each on p38, ERK, IL-10 and dusp. This model revealed that perturbations of ERK
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do not affect p38 phosphorylation levels, but perturbations of p38 negatively affect
ERK phosphorylation levels. This is in total accordance with the experimental data.
Chemical inhibition of ERK did not influence p38 phosphorylation levels, whereas
the chemical inhibition of p38 translated into a higher phosphorylation level of ERK
(Klotz et al., 2011).
Moreover, ERK but not p38 positively affects IL-10 production after Av17 treat-
ment. This is in accordance with a recent publication suggesting a linear correlation
between the strength of ERK phosphorylation and IL-10 production in different cell
types (Kaiser et al., 2009).
Taken together, this part of my thesis characterises the signalling mechanisms ad-
dressed by the immunomodulatory molecule Av17 in macrophages. Using a success-
full approach that interlaces experiments and modelling, I present a mathematical
model that can explain the biological processes addressed by the parasite A. viteae
to induce IL-10 production in macrophages and therefore blunt an effector immune
response that could kill the parasite. The ability of the parasite to explore regulatory
mechanisms of its host immune system allows the survival of the parasite for more
than one decade in the host.
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Part III.
Robustness of IL-10 production
and regulation
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13. Synopsis
Robustness is a property observed in biological systems that assures their function,
in spite of perturbations. I hypothesised that the interaction between parasitic nema-
todes and their mammalian host has been shaped to be robust, because the parasite
can persist for more than 10 years within its host, by blunting the proper immune re-
sponse that can eliminate the nematode. This suggests that the specific host-parasite
interaction has developed mechanisms of achieving robustness against biological vari-
ations. Moreover, I assumed that the IL-10 levels’ long term presence will strongly
influence the interaction between this parasite and its host. Here, I compared two
mathematical models with different feedback topologies and studied their properties
in terms of robustness to intrinsic and extrinsic noise. In this particular case, I used
the term robustness as a way of testing the variations of IL-10 steady state when
the system was intrinsically and extrinsically perturbed. I say that one perturbed
system is more robust than the other if the variations in IL-10 steady state of the
former are lower than the variations in IL-10 steady state of the latter. I defined
extrinsic noise as random perturbations imposed to the input of the system (Av17)
and I defined intrinsic perturbations as random perturbations on the whole param-
eter set. I suggest that the model selected in the previous part is robust to intrinsic
and extrinsic noise and that the negative feedback mechanism provides robustness to
this particular system. Moreover, I propose a method of model discrimination based
on a time dependent sensitivity analysis.
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14. A Monte Carlo analysis suggests that
integral feedback is more robust then
transient feedback
14.1. The models
I compared the selected model of Part II, Model DUSP (model 15 of table 10.1,
Figure 14.1) with model IL10 (model 17 of table 10.1, Figure 14.2). Both models
picture the signalling events that lead to IL-10 production and regulation. In the
first model, I assume that MAPK-induced DUSP promotes the negative feedback. In
the second model, I assume that IL-10 acts as the feedback promoter. Both models
comprise a transcriptional feedback and IL-10 production after a complex formation.
The models are distinguished by the type of feedback: the first model acts as an
integral feedback and the second one acts as a transient feedback. Transcriptional
feedbacks can be integral, depending on the parameter sets and degradation rate of
the elements. An integral feedback, integrates the error between the effective and
the desired output. It guarantees that the desired output level is reached, because
otherwise, the error would always be increasing. The parameter set defines the type
of feedback. I say that model DUSP has an integral feedback, because it achieves
almost perfect adaptation and that model IL10 has a transient feedback because the
element that implements the feedback, IL-10 protein, is transient.
14.2. Random perturbation of the input
The concentration of parasite and of its byproducts may not always be constant in
time. I assumed a biological variation of 20% around a basal value of Av17 concen-
tration. To study the effect of these variations on IL-10 steady state, I performed a
Monte Carlo analysis over the variable responsible for the input (s(t)).
I simulated the extrinsic noise by assuming that the variable ξ(t) of equation 2.15
is a Normal distribution with mean 0 and standard deviation 0.1, which samples 100
random values in the time interval between 0 and 100 [h], around 20% of the original
input value (s0 = 1). I interpolated the random function and summed it to the
unperturbed input value.
Figure 14.3 illustrates an example of the randomly perturbed input, s(t) of equa-
tion 2.15.
I generated 50 different perturbed inputs with the same characteristics described
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Figure 14.1.: Model DUSP: transcriptional feedback through DUSP - acts as an integral
feedback with almost perfect adaptation.
above. I fed these 50 different input functions to the model and, for each, I calculated
the steady state of IL-10.
Figures 14.4(a) and 14.4(b) plot the effect of extrinsic noise on IL-10 dynamics for
model DUSP and model IL10, respectively. The highest level of perturbation happens
when IL-10 reaches the maximal amplitude in both models, but model DUSP presents
the highest perturbation for IL-10 maximal amplitude and the lowest for IL-10 steady
state. Model IL10, in contrast, has a constant perturbation span over time. Both
models are robust to input perturbations, but at the level of IL-10 steady state, model
DUSP is more robust, as the histogram of Figure 14.6(a) indicates.
94
14.3. Random perturbation of the whole parameter set
v2	   v1	  
v7	  v8	  
v10	  
v9	  
il-­‐10m	  
S$mulus	  
(Av17)	  
ERK	  ERK	  
H3	   H3	  
v3	   v4	   p38	  p38	  
H3A	  
v13	  
IL-­‐10e	  
v11	  
v12	  
v14	  
v5	   v6	   A	  A	  
p	  p	  
p	  p	  
Figure 14.2.: Model IL10: transcriptional feedback through IL10 - acts as a transient feedback
where the steady state of IL-10 stays at half of the maximal amplitude of the signal.
14.3. Random perturbation of the whole parameter set
I simulated intrinsic noise by perturbing the whole parameter set of each model at
once. These were random perturbations of 20% around each element of the parameter
set. Assuming that the parameter set is P = {p1, p2, ..., pn}, for each pi, I generated
a random value ri, which was limited to 20% around pi, ie, pi ∗ 0.8 < ri < pi ∗ 1.2.
I did this for each parameter, constructing then a perturbed parameter set P˜ =
{p˜1, p˜2, ..., p˜n}. I created 50 different parameter sets P˜ and computed the IL-10
steady state for each.
I observed that intrinsic noise has a more profound impact when measuring IL-
10 steady state than extrinsic noise. Model DUSP presents less variations in IL-10
steady state than Model IL-10 when faced with changes in the whole parameter set.
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Figure 14.3.: Example of a perturbed input signal. 100 random values were sampled from a
Normal Distribution with mean 0 and standard deviation 0.1 around the original input value
and then interpolated.
(a) (b)
Figure 14.4.: Random perturbations on Av17 concentration affect IL10 production. IL-10
dynamics for (a) Model DUSP (b) Model IL-10.
Figures 14.5(a) and 14.5(b)show the time courses of IL-10 dynamics and Figure
14.6(b) shows the histogram of IL-10 steady state when both models are faced with
intrinsic perturbations. The large spread of values observed for model IL10, indi-
cates that IL-10 steady state varies much more than the IL-10 steady state of Model
DUSP, when exposed to variations. (Intrinsic noise provokes a standard deviation of
0.01 in model DUSP and of 0.07 in model IL10). As in the case of extrinsic pertur-
bation, model DUSP adapts better to perturbations than model IL10. This result
is expected, because model DUSP implements an integral feedback, which has the
characteristic of achieving adaptation. Hence, despite the fact that model DUSP
has broader variations at the maximal amplitude than model IL10, the former can
adapt, achieving residual values and a variation close to zero, whereas the latter, for
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(a) (b)
Figure 14.5.: Random perturbations on the parameter set affect IL10 production. IL-10
dynamics for (a) Model DUSP (b) Model IL10.
(a) (b)
Figure 14.6.: Histogram of IL-10 steady states when the model is subject to: (a) extrinsic
perturbations. (b) intrinsic perturbations. Blue: Model DUSP. Red: Model IL10.
the studied parameter sets, cannot attain perfect adaptation.
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15. Feedback provides robustness in
model DUSP
I pruned the arm responsible for the feedback mechanism on each model and I did the
Monte Carlo analysis described in chapter 14 on these models without feedback. I
compared the model with feedback and without feedback. The Monte Carlo analysis
here described, consists of simulating extrinsic and intrinsic noise (as explained in
chapter 14)
15.1. Extrinsic noise
The feedback mechanism clearly provides robustness to model DUSP. Model IL10
is slightly more robust with feedback than without in terms of IL-10 steady state.
Interestingly, in terms of maximal concentration of IL-10, the models have opposite
behaviours when the feedback is cut out. In model DUSP, the feedback attenuates
the maximal concentration of IL-10, whereas in model IL10, it amplifies it. Figure
15.1 shows the perturbations of model DUSP, with and without feedback.
(a) (b)
Figure 15.1.: Comparison of model DUSP with feedback (Red) and without (Blue). Feedback
provides robustness against extrinsic noise in terms of IL-10 steady state. (a) IL-10 dynamics.
(b) Histogram of IL-10 steady state.
Interestingly, a feedback mechanism does not bring much of robustness to model
IL10. In the absence of feedback, the dynamics of IL-10 are sustained and the
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maximal amplitude is lower than in the model IL10 with feedback. Figure 15.2
compares model IL10 in both versions.
(a) (b)
Figure 15.2.: Comparison of model IL10 with feedback (Red) and without (Blue). Feedback
provides robustness against extrinsic noise in terms of IL-10 steady state. (a) IL-10 dynamics.
(b) Histogram of IL-10 steady state.
15.2. Intrinsic noise
Intrinsic noise has a very similar effect on model DUSP as extrinsic noise, when
comparing this model with and without feedback. Figure 15.3 is very similar to
Figure 15.1.
(a) (b)
Figure 15.3.: Comparison of Model DUSP with feedback (red) and without (blue), when
subject to intrinsic noise. (a) IL-10 dynamics. (b) Histogram of IL-10 steady state.
The difference in robustness between model IL10 with and without feedback, is
more striking when both models are subject to intrinsic noise. In this case, model
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IL10 without feedback is clearly more robust than its counterpart with feedback, as
Figure 15.4 shows.
(a) (b)
Figure 15.4.: Comparison of Model IL10 with feedback (red) and without (blue), when subject
to intrinsic noise. (a) IL-10 dynamics. (b) Histogram of IL-10 steady state.
Negative feedback mechanisms bring about robustness at the cost of maximal am-
plitude, that is, a system with a negative feedback mechanism is, by definition, more
robust than the same system without feedback, where the former does not reach
the same maximal amplitude as the latter. Model IL10 goes against this hallmark
of feedback regulation. In this particular case, the absence of a feedback mecha-
nism lowers the maximal concentration of IL10. This happens because the maximal
value of the variable IL10e(t) was normalised to 1. By pruning the arm that pro-
vides feedback to model IL10, I set the reaction v2 = k2 ·ERKp (t) · IL10e (t)h, to
v2 = k2 ·ERKp (t). This corresponds to setting the variable IL10e(t) to its maximal
value, 1. To override this problem, the normalisation of IL10e(t) could be done by
setting its maximal value to 100, for instance.
Model DUSP and model IL10 have opposite behaviours when the feedback is can-
celled. Model DUSP has a higher amplification and higher variation of IL-10 steady
state, when the feedback mechanism is cut. Model IL10 has a lower amplification
and a lower variation without regulation.
The difference between these two models without feedback lies on the production
of DUSP and on the specific parameter sets. The fact that model IL10 is more
robust to noise when there is no feedback, is due to its particular parameter set and
to IL10e(t) normalisation factor.
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16. Single parameter perturbations do
not affect the overall robustness of
the models
I perturbed each single parameter on 10%, 20% and 50% around its original value
and analysed its effect on IL-10 steady state. I calculated the sensitivity of each
perturbation, using the formula 2.18.
Model DUSP Table 16.1 shows the sensitivity of each parameter of model DUSP
to the perturbations mentioned above.
-10% -20% -50% 10% 20% 50%
k1 -0.89 -0.79 -0.49 -1.09 -1.19 -1.49
k2 0.99 0.99 0.99 0.99 0.99 0.99
k3 -0.009 -0.008 -0.006 -0.01 -0.01 -0.01
k4 0.010 0.01 0.008 0.01 0.01 0.01
k5 -0.89 -0.79 -0.49 -1.09 -1.19 -1.49
k6 0.99 0.99 0.99 0.99 0.99 0.99
k7 -0.89 -0.79 -0.49 -1.09 -1.19 -1.49
k8 0.99 0.99 0.99 0.99 0.99 0.99
k9 1 1 1 1 1 1
k10 -0.89 -0.79 -0.49 -1.09 -1.19 -1.49
k11 -0.89 -0.79 -0.5 -1.1 -1.2 -1.5
k12 1 1 1 1 1 1
k13 -0.89 -0.79 -0.5 -1.1 -1.2 -1.5
k14 1.19 1.25 1.92 1.13 1.11 1.08
k15 1 1.01 1.01 1 1 1
k16 -0.91 -0.81 -0.5 -1.1 -1.22 -1.53
k17 1 1.01 1.01 1 1 1
k18 -0.01 -0.01 -0.008 -0.01 -0.02 -0.02
k19 ∼0 ∼0 ∼0 ∼0 ∼0 ∼0
Table 16.1.: Table of sensitivities for model DUSP.
A detailed analysis of the table indicates that most of the parameters are insensitive
to changes (section 2.2.4). Two main groups can be defined: parameters with positive
sensitivities and parameters with negative sensitivities.
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Parameters k2, k4, k6, k8, k9, k12, k14, k15 and k17 have positive sensitivities. This
means that an inhibition of the parameter will reflect an inhibition of the output.
Attempting to Figure 14.1, the reader can observe that the positive parameters corre-
spond to the reactions of dephosphorylation (k2, k4, k6, k8), complex disagreggation
(k9) and IL-10 degradation (k12, k14), except for reactions k15 and k17, which cor-
respond to DUSP transcription and translation. ERK and p38 induce the parallel
expression of two concurrent genes: il-10 and dusp. DUSP represses ERK and p38
and, consequently, represses IL-10 production. More DUSP increases the dephospho-
rylation rate of ERK and p38, hence decreasing IL-10 concentration. So, if k2 goes
up, IL-10 maximal value should go down. It might be that, at steady state, IL-10
changes at the same rate as ERK dephosphorylation rate changes. It should also be
noted that the parameters responsible for DUSP transcription and translation are
the only ones that have positive sensitivities and refer to production. All the others
refer either to degradation or disaggregation. Also interesting is that all positive
sensitivities, except the one referent to IL-10 degradation, have the same value for
different perturbations.
The second group, the negative sensitivities, is mainly constituted by reactions of
phosphorylation, complex formation and production, except for the case of DUSP.
The sensitivity of the parameter for dusp mRNA degradation is positive and for DUSP
protein degradation is close to zero. All negative sensitivities vary with the specific
perturbation value (except for k4 and k18, which yield a sensitivity value close to
zero) and the perturbation of 50% yields the highest sensitivity. Interestingly, in the
group of positive sensitivities, all parameters present the same sensitivity for different
perturbations, except k14, which yields the highest sensitivity when the perturbation
is -50%. Nevertheless, a system is said to be sensitive when S >> 2 (2.18). This last
observation is in line with the last chapter, where I show that model DUSP is robust
to variations. This sensitivity analysis shows that the system is also robust to single
parameter perturbations.
Model IL10 Table 16.2 shows the sensitivities of model IL10. They were calculated
as previously described for model DUSP.
Interestingly, model IL10 has a very defined pattern of sensitivities. All phosphory-
lation reactions have negative sensitivities, whereas the respective dephosphorylation
reactions have a positive S. But, contrary to the previous case, the complex formation
X2, il-10 mRNA expression and IL-10 protein production have negative sensitivities
and their counterpart reactions (complex disagreggation, IL-10 (mRNA and protein)
degradation) have positive sensitivities.
All sensitivities were below two for both models. Therefore, I can conclude that
both models are robust to single parameter perturbations.
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-10% -20% -50% 10% 20% 50%
k1 -0.29 -0.27 -0.2 -0.33 -0.35 -0.4
k2 0.3 0.28 0.23 0.32 0.33 0.36
k3 -0.2 -0.27 -0.2 -0.33 -0.35 -0.4
k4 0.3 0.29 0.24 0.33 0.34 0.36
k5 -0.33 -0.3 -0.22 -0.37 -0.4 -0.46
k6 0.34 0.32 0.27 0.36 0.37 0.4
k7 -0.33 -0.31 -0.22 -0.38 -0.4 -0.46
k8 0.34 0.33 0.28 0.37 0.38 0.41
k9 0.35 0.33 0.28 0.37 0.38 0.41
k10 -0.34 -0.31 -0.22 -0.38 -0.41 -0.47
k11 -0.34 -0.31 -0.22 -0.39 -0.41 -0.47
k12 0.35 0.33 0.28 0.37 0.38 0.41
k13 -0.34 -0.31 -0.22 -0.39 -0.41 -0.47
k14 0.35 0.33 0.28 0.37 0.38 0.41
Table 16.2.: Table of sensitivities for model IL10.
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17. Time dependent sensitivity analysis
I conducted a time dependent sensitivity analysis by applying infinitesimal changes
in each parameter and checking its effect on IL-10. This method, presented in section
2.2.5 shows how the sensitivity of a specific element to a single parameter changes
over time, in terms of its response coefficients. The aim of this chapter is to propose a
method of model selection based on a dedicated experiment, which tests the element
that presents a higher difference between the concurrent models.
Response coefficients indicate the change in a species concentration after infinites-
imal perturbations. I calculated the response coefficients for IL-10. The infinitesimal
perturbations were imposed to each parameter and to the initial condition of each
species.
17.1. Model DUSP
Figure 17.1.: Positive and negative sensitivities of model DUSP with the highest absolute
maximal values. Red: positive sensitivity (k1 with maximal amplitude of 17.7 at t=5.6.
Green: Negative sensitivity k14 with minimal amplitude of -8.78 at t= 22.7
Figure 17.1 shows the response coefficients for IL-10 over time. k1, the parameter
responsible for ERK phosphorylation, influences IL-10 the most, at t=5.6h. Inter-
estingly, IL10 reaches maximal amplitude at t=5.5h. The parameters responsible for
species phosphorylation (k1, k3, k5 and k7) are all positive and have a time course
similar to IL-10 species. k10 (X2 complex disaggregation), k11 and k13 (il-10 mRNA
and IL-10 protein production), kk16 and kk18 ( DUSP (mRNA and protein degrada-
tion), also have positive sensitivities. Reversely, the parameters that dephosphorylate
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the model species (k2, k4, k6 and k8), have negative sensitivities, although the ab-
solute time course is similar to the previous case. Other parameters with negative
sensitivity and transient time course are k9 (complex formation X2), k12 and k14 (il-
10 mRNA and IL-10 protein degradation, respectively), k15 and k19 (DUSP mRNA
production), and k17 (DUSP protein production). Interestingly, IL-10 and DUSP
have reverse characteristics. If the parameters for IL-10 production have a positive
time course sensitivity, those for DUSP have a negative time course sensitivity and
vice versa. The fact that DUSP plays an indirect role on IL-10 decrease explains
this observation. The positive sensitivity with the highest maximal amplitude is
k1 and the negative sensitivity with the highest minimal amplitude is k8, which is
the parameter responsible for histone 3 dephosphorylation. Figure 17.2 shows both
sensitivities.
Figure 17.2.: Sensitivity with highest positive and negative maximal amplitudes, model
DUSP.
Atypical time dependent sensitivities I selected the sensitivities with an atypical
time course and analysed why they are different from the typical pattern of sensitiv-
ities, that has a transient time course.
Figure 17.3 shows the parameters and initial conditions with higher sensitivity and
higher dynamic changes.
If a parameter switches its influence on a certain species over time, e.g., if the time
dependent sensitivity analysis change from positive to negative, then the parameter
changes its influence over the species along the specific temporal trajectory. This hap-
pens with the sensitivity of IL-10 to p38p[0], the initial condition of phosphorylated
p38 (Orange curve of Figure 17.3).
To understand better how this sensitivity correlates with IL-10 dynamics, I calcu-
lated the parametric plot, represented in Figure 17.4.
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Figure 17.3.: Most relevant time dependent sensitivities of Model DUSP. Pink: parameter
k18 - DUSPp degradation; Orange: P38p initial condition;Violet: IL10e initial condition.
Figure 17.4.: Parametric plot of IL-10 dynamics and the time dependent sensitivity of IL-10
to p38p initial condition.
IL-10 dynamics and the sensitivity of p38p[0] grow until the sensitivity of p38p[0]
reaches its maximum (0.11 AU). IL-10 keeps growing and the sensitivity of IL-10
to p38p[0] starts decreasing. When IL-10 reaches 0.5 AU (the half of its maximal
amplitude) the sensitivity of IL-10 to p38p[0] switches from positive to negative. This
means that at IL-10 half amplitude, p38p[0] starts having a negative influence on this
cytokine.
A sensitivity of value 1 means that a perturbation of value x on a specific parameter
will reflect a perturbation of the same value x on the output of the system. The
sensitivity of IL-10 to IL-10 initial condition is 1. This trivial observation leads to
the analysis of the sensitivity time course. The violet curve of Figure 17.3 shows that
this sensitivity decreases with time, approaching zero. A sensitivity that tends to
zero means that a very high perturbation has a very small effect in the output. To
better understand why is it that the dynamic sensitivity of IL-10 to its own initial
condition is not constant in time, I analysed the parametric plot shown in Figure
17.5(a).
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(a) (b)
Figure 17.5.: (a) Parametric plot of IL-10 dynamics and the time dependent sensitivity of
IL-10 to IL-10 protein initial condition (b) parametric plot between k18 and IL-10.
IL-10 amplitude grows from 0 to 1 as the sensitivity of IL-10 to its initial condition
decreases from its initial value 1. When S=0.75, IL-10 reaches its maximal value
and starts decreasing until approaching zero. This sensitivity has a time course that
resembles a negative exponential curve.
The sensitivity of IL-10 to perturbations on k18, which is the degradation rate of
DUSP protein has a contrasting behaviour with the sensitivity of IL-10 to pertur-
bations on its own initial condition. The former has an exponential trend and the
latter, a logarithmic trend. DUSP has a slow growth and a sustained time course at
t=40 000 h. It therefore indicates a very low degradation, confirmed by the value of
k18 = 0.0001, the parameter responsible for its degradation. DUSP is a phosphatase
that dephosphorylates p38p and ERKp, consequently decreasing the levels of IL-10
production. Figure 17.5(b) depicts the dynamics of DUSP and the parametric plot
between k18 and IL-10.
The time course of this sensitivity resembles a logarithmic curve (as opposed to
the previously analysed sensitivity) and follows the sustained dynamics of DUSP.
Although with opposite dynamics, the relation between k18 perturbations and IL-10
is similar to the relation between IL-10 and the perturbation of its initial condition,
as Figures 17.5(a) and 17.5(b) show.
17.2. Model IL10
Figure 17.6 shows the time dependent sensitivities of IL-10 to each parameter and
initial condition.
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Figure 17.6.: Response coefficients for IL-10, model IL10. Represents the sensitivity of IL-10
to infinitesimal changes in all the parameters and initial conditions along time.
The sensitivities of model IL10 are all transient and mostly follow the dynamics
pattern of IL-10. Positive sensitivities correspond to the processes of phosphorylation,
production and constitution, whereas negative sensitivities correspond to processes
of dephosphorylation, degradation and disaggregation. The exception to this obser-
vation lies on the sensitivities to the initial conditions of X2, il-10 mRNA and IL-10
protein, which has a positive and negative sensitivity.
(a) (b)
Figure 17.7.: (a) Time dependent sensitivity of IL-10 to its initial condition, (b) parametric
plot between IL10 and its sensitivity to its initial condition
Atypical time dependent sensitivities IL-10 sensitivity to its own initial condition
(IL10[0]) starts in 1 and changes to the negative side of the axis when IL-10 has an
amplitude of 0.35. It keeps on decreasing, reaching its minimal amplitude (highest
negative sensitivity) of -3.6 when IL-10 reaches its maximum. At this point, both
111
17. Time dependent sensitivity analysis
elements decrease: IL-10 decreases until its steady state of 0.6 AU and the sensitivity
approaches zero at time t=80h.
17.3. A method for model discrimination
When having two concurrent models, it is not always clear which model can best
represent the biological system. To help select the best model, I propose a method
for optimal experimental design that suggests an experiment on the specific parameter
that best distinguishes the models and the specific time point. This method consists
of the following steps:
• Have two concurrent models;
• Calculate the time dependent sensitivity analysis (RC) for each parameter of
each model;
• Find the maximal difference between the RCs of each model, i.e., the
Max(RCkiM1-RCkiM2);
• This suggests a specific experiment that should address the parameter with
Max(RCkiM1-RCkiM2), at the specific time point when this difference is maxi-
mal.
Figure 17.8 shows the time dependent sensitivity analysis for all the parameters
and initial conditions of both models.
(a) (b)
Figure 17.8.: Differences between the time dependent sensitivity analysis of model DUSP
and model IL10. (a) Parameter (b) initial conditions
In the case of model DUSP and model IL10, the Max(RCkiM1-RCkiM2) happens
for parameter k1 at time point t=7.5 h. This parameter is responsible for ERK
phosphorylation and is represented in Figure 17.9.
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Figure 17.9.: Comparing the RC of k1 between Model DUSP and Model IL10. Red: k1 of
Model DUSP; Green:k1 of Model IL10; Blue: Difference between both
Hence, this method suggests that the perturbation of ERK phosphorylation should
be experimentally tested at time point t=7.5 h and observe which model best follows
the experimental data.
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18. Discussion of Part III
Robustness, sensitivity and homeostasis are properties of biological systems that in-
terconnect with each other. These three properties provide a dynamic self-regulation
of the system, by setting the functional limits of each element of the network. A ro-
bust gene network system might have alternative mechanisms of gene expression that
assure the transcription of the gene in question when one of the arms of the network
is deleted (robustness by redundancy). The same system should also be sensitive
enough to sense changes in the environment and change its behaviour accordingly.
The orchestration of these two figures together, brings about the definition of home-
ostasis, which is the dynamic self-regulation of open or closed systems, ensuring the
constancy of its performance (Cannon, 1932). Self regulation, or feedback, is one
strategy of living systems to achieve robustness.
One hypothesis of my PhD thesis, mentioned in chapter 4.1, is that a negative feed-
back mechanism regulates the production of IL-10 in macrophages after exposure to
an immunomodulatory molecule of the parasitic nematode A.viteae. The available
experimental data strongly suggest that this feedback occurs at the MAPK level,
as I indicated in Part II of this work. I analysed the robustness of two models by
studying the effect of extrinsic and intrinsic noise on the level of IL-10 steady state.
Extrinsic noise reflects the possible variations on the total concentration of secreted
Av17. These perturbations may happen because the total parasite population may
vary along time. Intrinsic noise refers to perturbations on the parameter set and
reflects the possible biological variation within a cell. I used a Monte Carlo analysis
to simulate the extrinsic and intrinsic noise assuming a variation of 20% around the
unperturbed value in both cases. I compared two concurrent models of IL-10 produc-
tion and regulation: model DUSP, where the regulation of IL-10 happens through the
activation of a phosphatase that dephosphorylates the signalling pathways responsi-
ble for IL-10 production (integral feedback); model IL10, where IL-10 itself regulates
its own production by deactivating the signalling pathways responsible for its pro-
duction (transient feedback). Both models implement a transcriptional feedback and
its negative form is known to filter out noise (Blüthgen, 2010)
The results of this work indicate that model DUSP, the model selected after bio-
logical evidences, is more robust then model IL10.
When analysing the effect of extrinsic noise on IL-10 steady state, model DUSP is
slightly more robust than mode IL10 (although both models are relatively robust).
Nevertheless, the analysis of IL-10 time course suggests that model DUSP can better
adapt to changes in the environment. This is explained by the fact that model DUSP
implements an integral feedback. Integral feedback is a common topology in control
engineering to achieve perfect adaptation and override the effect of perturbations
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(Ang et al., 2010; Cloutier and Wellstead, 2010). In accordance, model DUSP can
adapt to variations and filter out intrinsic and extrinsic noise. Consequently, IL-10
reaches residual values at steady state, independently of the perturbation.
A characteristic of negative feedback regulation is that systems are normally more
robust to perturbations, but they cannot achieve such high maximal amplitude as
systems without feedback can. This is observed in model DUSP but, interestingly,
not in model IL10. The models have opposite behaviours when the feedback is cut
out. In model DUSP, the feedback attenuates the maximal concentration of IL-10,
whereas in model IL10, it amplifies it. This unexpected result can be understood by
the fact that IL-10 varies from 0 to 1 and, when the variable IL10e(t) is cut out from
the reaction that provides feedback, it increases the strength of the dephosphorylation
reactions, v2 and v4.
To further analyse the robustness of these systems, I did a sensitivity analysis by
varying each parameter at the time. I varied each single parameter 10%, 20% and
50% around its original value and calculated the sensitivity of IL-10 steady state
to each parameter. Results indicate that both systems are not sensitive to single
parameter changes at the level of IL-10 steady state, which goes in line with the
results from the previously described Monte Carlo analysis.
To understand if the models are always insensitive to changes, I computed a
time dependent sensitivity analysis, which tells how the sensitivity of one param-
eter changes over time. This is specially of interest when studying signalling and
adaption mechanisms. This method has been suggest by Ingalls and Sauro (2003)
and has been applied on studying the systemic properties of yeast, when faced with
perturbations along a temporal trajectory (Klipp et al., 2005; Kühn et al., 2008).
The method assumes that each parameter and the initial condition of each species is
subject to infinitesimal changes over time. In the context of this thesis, this method
revealed that, for IL-10 steady state, most parameters and initial conditions are in-
sensitive to changes. Nevertheless, when IL-10 reaches its maximal amplitude, the
models also achieve their maximal sensitivity. The most sensitive parameter of model
DUSP is the parameter responsible for ERK phosphorylation.
A sensitivity can be positive or negative, and its sign indicates if the effect of the
specific parameter/initial condition on the output is positive or negative. In model
DUSP, the parameter responsible for IL-10 degradation has a negative effect on IL-10,
which is an expected result.
The parameters referring to phosphorylation, activation and production reactions
are positive, in contrast with the parameters referring to dephosphorylation, degrada-
tion and complex disagreggation, which are negative in both models. Species DUSP
(protein and mRNA) are the exception to this pattern: the sensitivities of IL-10
to these parameters are positive when referring to mRNA and protein degradation
and negative when referring to DUSP transcription and translation. This result was
expected, because DUSP is responsible for IL-10 degradation.
Finally, I suggest a method of model selection by optimal experimental design. This
method consists of computing the differences between the corresponding sensitivities
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of both models and experimentally testing the parameter that yields the maximal RC
difference between models, at the specific time point when this difference is maximal.
In terms of amplitude, the most striking difference is between parameter k1 of both
models and, in terms of dynamics, are the parameters k10 and k14. These parameters
can be experimentally investigated, as future work. Nevertheless, it is important to
mention that, experimentally, it is practically impossible to test infinitesimal varia-
tions of one element and its influence in the others. This method is of value to know
which element can best distinguish between two concurrent models, and at which
time point this element should be experimentally tested.
This part of my thesis suggests that different feedback topologies influence the
robustness of the biological network and proposes a method of model selection by
optimal experimental design.
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Part IV.
General discussion, summary and
outlook
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19. General discussion and summary
One of the most fascinating results of observing host-parasite interactions is the el-
egance with which parasitic nematodes divert an effector immune response of their
host to a blunted immune response. This diverting process may protect the host
against allergies and auto-immune diseases. Understanding how parasitic nematodes
modulate their host immune response could be a breakthrough to research and fur-
ther develop medicines against immune disorders like allergies or auto-immune dis-
eases. As a first investigation step in this direction, I aimed at understanding which
molecules and pathways are involved in the modulation of the immune response. To
achieve this, I used a systems biology approach, which uses mathematical methods
to help understanding biological interactions. This is a desireable procedure when
studying specific questions of host-parasite interactions. Combining experimental
data with mathematical models holds various benefits. It offers the investigator not
only a panorama of the problem at hand, but also allows to undergo in silico experi-
ments that may not be realistic to do in vitro or in vivo for a question of time, money
and resources.
The main objective of this thesis was to understand the host-parasite interaction
that leads to the downregulation of the host’s immune response directed against the
parasite. To examine the questions that arose from here, I interlaced mathematical
modelling with experimental data1.
The parasitic nematode A.viteae secretes an immunomodulatory molecule, Av17,
that binds to the macrophages of its host and induces the expression of the anti-
inflammatory cytokine IL-10, which modulates the host immune response. I con-
structed mathematical models based on literature and on experimental data to un-
derstand which pathways this nematode exploits to induce IL-10 production. These
models hypothesised that Av17 activates the MAP kinases ERK and p38 and that
both are essential for IL-10 production (Yang et al., 2007; Zhang et al., 2006). Ac-
cording to Lucas et al. (2005); Staples et al. (2007); Gee et al. (2007), CREB, SP1 and
STAT3 are transcription factors involved in il-10 transcription. I constructed mathe-
matical models to describe these facts and the experimental data, showing that Av17
stimulated macrophages express IL-10 with transient dynamics (Figueiredo et al.,
2009). The first hypothesis of this mathematical model, that Av17 activates the sig-
nalling pathways ERK and p38, was experimentally validated. Western blots testing
the phosphorylation of ERK and p38 have shown that Av17 indeed activates the
signalling pathways ERK and p38, but not JNK in macrophages exposed to this
1All the experimental data presented in this thesis was provided by the Department of Parasitology
of the Humboldt-Universität, Berlin.
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immunomodulatory molecule. The second hypothesis, that ERK and p38 are both
necessary for IL-10 transcription was also experimentally tested, again validating this
model hypothesis. The blockage of ERK or p38 showed that IL-10 production de-
pends on both kinases (Klotz et al., 2011). Moreover, the involvement of CREB and
STAT3 in il-10 transcription, has been stated by the same authors.
To understand the origin of the transient IL-10 dynamics, I hypothesised that
a negative feedback, acting on the signalling pathways, regulated IL-10 expression.
Macrophages express the IL-10 receptor complex on their surface and the literature
suggests a negative autoregulatory role for IL-10 for LPS or lipoprotein stimulated
IL-10 production in monocytes and monocyte-derived macrophages (de Waal Male-
fyt et al., 1991; Giambartolomei et al., 2002; Staples et al., 2007; Ward et al., 2005).
The deactivation of signalling pathways can happen either by the action of phos-
phatases or kinases (Kholodenko, 2006). Accordingly, I assumed that the feedback
mechanism acting on ERK could happen by phosphatase activation or kinase inhibi-
tion. I tested the kinetics of IL-10 when both models were faced to increases in the
input and I observed that kinase inhibition is a more efficient signal amplifier than
phosphatase activation, but the latter is more robust to input perturbations than
the former. Moreover, the feedback mechanism of kinase inhibition is non-linear, so
it quickly activates and deactivates the ERK signal, meanwhile keeping a constant
plateau for ERK duration. In contrast, regulation by phosphatase activation phos-
phorylates and dephosphorylates ERK in a linear fashion (Figueiredo et al., 2009).
To further characterise the different feedback mechanisms, I used the concepts of
integral, maximal amplitude, steady state, overshoot and signal duration. In terms
of signal concentration (total and maximal), kinase inhibition produces more IL-10
than phosphatase activation. That model can also adapt better, showing a higher
overshoot than phosphatase activation. But phosphatase activation yields a longer
IL-10 duration than kinase inhibition. This is in accordance with Hornberg et al.
(2005b), who states that “...kinases control amplitudes more than duration, whereas
phosphatases tend to control both.” I further investigated the effect of perturbations
on the specific elements of the network. I did a sensitivity analysis, by imposing
perturbations on the phosphorylation level of ERK or p38, and checked the effect of
these perturbations on p38, ERK and IL-10. I observed that there is an autocrine
crosstalk that connects ERK, p38 and IL-10. This sensitivity analysis revealed a
wiring scheme connecting p38 to ERK through IL-10, but not ERK to p38. That
is, perturbations on p38 affect ERK activity through the IL-10 feedback mechanism,
but ERK perturbations do not affect p38.
In Part II of this thesis, I compared the ERK and p38 dynamics measured ex-
perimentally with the predictions of the same components, for kinase inhibition and
phosphatase activation. Both models show a transient phosphorylation of ERK and
a sustained phosphorylation of p38, but the experimental data show a transient ac-
tivation of both kinases. Faced with these facts, I included a feedback mechanism
acting on p38. I did a systematic analysis to test the alternative regulation motifs
with biological significance that combine different regulation approaches. The sys-
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tems biology approach helped identifying a model that can explain the data and
make correct predictions. In this approach, experiments were done after theoretical
predictions were made, or the model was refined after experimental evidence (Figure
10.2). The selected mathematical model identified DUSPs as the molecules respon-
sible for the regulation mechanisms of IL-10 production. This model hypothesised
that ERK and p38 independently activate DUSPs and these, in turn, deactivate the
original MAPKs.
DUSP activity was experimentally measured, as a dedicated experiment to vali-
date the model hypothesis about the regulation mechanism. In vitro experiments
identified DUSP1 and DUSP2 as regulators of IL-10 production. To confirm, tests
in Av17 stimulated macrophages of dusp1−/− mice revealed that IL-10 kinetics are
sustained, in contrast with the transient IL-10 kinetics of wild type animals. More-
over, experiments in vivo revealing the presence of DUSP1 and DUSP2, have very
similar dynamics to the DUSP in silico prediction.
A sensitivity analysis showed that DUSP mediates crosstalk between individual
MAPKs. The wiring scheme of ERK, DUSP and p38 reveals that all these elements
are interconnected, but one cannot scrutinise the specific influence of one element
on another. This was done in silico by perturbing one element of the network and
testing the effect of this perturbation in the other elements. The model revealed that
ERK perturbations affect only IL-10 expression and that p38 perturbations affect
IL-10 and DUSP in a linear manner. Interestingly, the perturbation of p38 has a
negative impact in ERK phosphorylation, i.e., inhibition/increase of p38 produces
a increase/inhibition in the phosphorylation levels of ERK. Moreover, the reverse
mechanism was not verified, i.e., ERK perturbations have no effect on phospho-
p38 levels. This was experimentally tested and the in vitro results agree with the
model. The combination of modelling and experiments shown in this part of my
thesis, allowed to select a model that can correctly predict experimental data and
make right and reliable predictions.
My hypothesis, in Part III, is that the host-parasite interaction studied in this
work has been shaped to be robust. I tested wether the selected model in part II is
robust to noise, by comparing it with a model that implements regulation through
IL-10. This part of my thesis discussed the robustness of IL-10 steady state of two
concurrent models when exposed to intrinsic or extrinsic noise. Based on a Monte
Carlo analysis, I suggest that the model selected after the experimental evidences is
more robust than its concurrent. This model implements an integral feedback and
has a better signal adaptation than the model with transient feedback.
Mathematical modelling is an elegant and efficient way of making in silico predic-
tions that otherwise would be too expensive in terms of time and money. Thereby,
it effectively - and at low costs - identifies new experiments that may give further
information about the biological system. Indeed, the combination of experimental
approaches and mathematical modelling allowed to understand how the nematode
A.viteae explores the regulation mechanisms of the immune system by activating
specific signalling events that manipulate macrophage functions and allow its evasion
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to the expectable immune attack.
Figure 19.1 shows the main results of this work.
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Figure 19.1.: Flow diagram describing the main results of this thesis.
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20. Outlook
In this particular work, the elucidation of the signalling mechanisms that induce the
regulation of immune cells after exposure to immunomodulatory molecules of nema-
todes, brought up the questions explored in the next sections. The contribution of
this work will allow approaching these further questions with a greater understanding.
20.1. Discrimination of crosstalk between ERK, p38 and
JNK in IL-10 production and regulation - zooming in
It is not yet clear the role of the MAPK JNK in this biological system. The inhibition
of this MAPK did not affect cytokine production in Av17 stimulation. The crosstalk
established between ERK, JNK, p38 and DUSPs is not yet fully understood. More-
over, the presence of IL-12/23p40 was also reported for this system. The connections
between IL-10, IL-12/23p40, the MAPKs and the DUSPs could be first approached
by a mathematical model focusing on the particular signalling events that regulate
this biological system.
20.2. A systemic view of the effect of Av17 manipulated
macrophages at the organismic levels - zooming out
In this thesis, I suggest a mathematical model that explains how Av17 triggers
macrophages to produce IL-10. However, how this immunomodulatory molecule
binds to the macrophages is still an open question. The malarial parasite Plas-
modium falciparum activates the ERK signalling cascade through the induction of
proteins that bind to the scavenger receptor CD36 (Yipp et al., 2003), diverting the
monocytes to IL-10 production. The ERK signalling cascade is also activated by
Leishmania mexicana, but through FccR (Yang et al., 2007). In addition, Buxbaum
and Scott (Buxbaum and Scott, 2005) have shown that removal of IL-10 or FccR
leads to resolution of L. mexicana disease. This suggests that engagement of FccR
through parasite products or immune complexes leads to IL-10 production. The eggs
of the blood fluke Schistosoma mansoni release phosphatidylserines that bind to and
activate Toll-like receptor 2 (TLR2), an event leading to the production of IL-10.
All of these receptors (CD36, FccR, and TLR2) signal through the ERK signalling
cascade, which makes them attractive for studying the production and regulation
of this cytokine via Av17. It is, however, likely that the recognition of products of
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parasitic nematodes is highly specific and that no common receptor recognising the
products of different parasites exists (Perrigoue et al., 2008).
After exposure to Av17, macrophages alter their functions. The effect of these
altered macrophages in the host, is a question that remains unanswered. The type
of stimuli that these cells receive, defines the macrophage phenotype. Av17 altered
macrophages show notable resemblance to M2b macrophages. M2b macrophages can
be generated after p38 and ERK activation, through Fc-γ receptors and inflammatory
signals such as TNF (Anderson and Mosser, 2002b,a; Sutterwala et al., 1998). M2b
macrophages and Av17 stimulated macrophages induce both IL-10 production and a
Th2 response.
With which cells do these altered macrophages interact and how do they signal to
other cells? The effects of IL-10 on the macrophage population in particular and on
the immune system in general is still an open question.
To explore these questions, I suggest the performance of a high troughput experi-
ment (e.g., microarray experiment) to analyse the genotypic differences between the
stimuli that lead to different macrophage phenotypes. Av17 stimulated macrophages,
macrophages without any stimuli and M2b macrophages could be tested at several
time points. A preliminary microarray data analysis was performed and described in
Appendix C.
The answer to these questions can open the doors to develop a model that depicts
these interactions and better understand this particular host-parasite interaction in
a more systemic view. Furthermore, the knowledge acquired from the analysis of
the host-parasite interactions might pave the way for developing pharmaceutical ap-
proaches to fight allergies and autoimmune diseases with immunomodulatory proteins
of parasitic nematodes.
128
Part V.
Appendix
129

A. Notations, estimated parameters and
materials and methods
A.1. Notations
The models are available in the Systems Biology Markup Language (SBML) format,
which is a widely accepted standard of ODE models in systems biology (Hucka et al.,
2003).
A.2. il-10 mRNA half-life
Half-life values of il-10 mRNA were extracted from the literature.
Values of il-10 mRNA are shown in Table A.1 and the respective parameter (k12)
was set to the average of the available values. Fitting was performed with COPASI
(Hoops et al., 2006), using the algorithms for evolutionary programming and simu-
lated annealing, available in the software package of COPASI.
Cell type Stimulus il-10 mRNA t1/2[h] Reference
MNT1 Nonstimulated 1.25 Brewer et al. (2003)
Leucocytes LPS 1.25 Gibson et al. (2001)
EL-4 cell Nonstimulated 1
PMA 3 Powell et al. (2000)
Table A.1.: Values of il-10 mRNA half-life extracted from literature.
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A.3. Estimated parameters of the studied models
Model 1 Model 2 Model MKP Model IL10
k1 2.17 0.09 0.05 0.78
k2 83.39 478.04 3.44 8.05
k3 8.87 0.87 0.84 0.73
k4 29.39 0.01 0.88 10
k5 0.08 3.83 0.54 1.06
k6 3.53 0.005 9.99 7.57
k7 0.19 0.58 9.95 0.45
k8 2.68 6.87 6.32 10
k9 9.43 6.42 9.65 7.53
k10 38.67 3.41 4.67 1.98
k11 85.17 10.52 10 9.67
k12 0.78 0.78 0.78 0.78
k13 0.49 0.39 0.49 0.54
k14 0.05 0.06 0.05 0.08
k15 - - 6.99 -
k16 - - 1.3 -
k17 - - 0.72 -
k18 - - 0.0001 -
k19 - - 0.0001 -
kf 85.09 - - -
h 2.54 1.09 - -
Table A.2.: Table with the parameter values of model 1, model 2, model MKP and model
IL10.
A.4. Materials and methods
IL-10 regulation in macrophages stimulated with Av17 and anti IL-10 receptor anti
body Peritoneal exudate cells from BALB/c mice that were flushed with PBS/2mM
EDTA from the peritoneum were used. These cells were seeded (2 million cells) into
wells of a 24 well plate in cDMEM (10% FCS, 1 mM L-Glutamin, 100 U/ml Peni-
cillin G and 100 µg/ml Streptomycin). After 2 hours, cells were washed twice with
cDMEM to get rid of non adherent cells. Remaining macrophages were treated with
0.5 µM Av17 or the same amount of SNAP, denaturated Av17, and Av17 in combi-
nation with 10 µg/ml anti-IL-10R ab or ab control for different timepoints (2h, 18h,
24h). Cells were afterwards washed with PBS, RNA was extracted (innuPREP RNA
Mini Kit, JenaAnalitk) and rewritten into cDNA (High Capacity RNA-to-cDNA Kit,
Applied Biosystems). To analyse the expression of IL-10, real time PCR by using the
FastStart Universal SYBR Green Master(Rox) Kit from Roche was performed. For
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normalization PPIA was used as housekeeping gene and the DeltaDeltact method
described for qRT-PCR was applied. The anti-IL-10R ab was kindly provided by
Dr. Hyun-Dong Chang, Deutsches Rheuma-Forschungszentrum Berlin. This exper-
iment was performed by Thomas Ziegler, Department of Parasitology, Humboldt-
Universität zu Berlin.
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B. Model discrimination lists
Table B.1.: Frequencies of each model on the top 10 list, AIC average and median.
Frequencies Average AIC Median AIC
model 17 10 model 17 -55.82 model 16 -12.93
model 19 10 model 18 -49.22 model 13 2.8
model 18 9 model 16 -48.91 model 19 18.41
model 29 9 model 1 -33.6 model 17 32.45
model 25 8 model 13 -28.91 model 21 36.82
model 2 7 model 11 -20.62 model 29 42.53
model 21 7 model 6 -16.78 model 2 44.11
model 4 6 model 15 -15.64 model 18 44.65
model 13 6 model 19 -10.71 model 4 45
model 16 6 model 9 -10.45 model 9 46.45
model 35 6 model 3 -6.19 model 11 53.32
model 6 5 model 8 5.13 model 15 54.26
model 9 5 model 25 10.27 model 14 54.93
model 15 5 model 14 15.63 model 27 57.02
model 1 4 model 4 21.09 model 25 58.77
model 3 4 model 21 21.31 model 12 59.54
model 7 4 model 12 22.67 model 7 62.62
model 11 4 model 27 22.88 model 20 62.71
model 14 4 model 2 23.99 model 33 67.25
model 27 4 model 24 25.37 model 5 69.04
model 5 3 model 29 42.97 model 6 70.32
model 20 3 model 7 48.29 model 28 70.67
model 8 2 model 20 51.6 model 10 71.22
model 12 2 model 33 60 model 1 72.53
model 24 2 model 10 65.44 model 8 75.26
model 28 2 model 28 66.83 model 23 75.26
model 10 1 model 5 67.6 model 3 75.87
model 23 1 model 26 67.71 model 24 81.34
model 26 1 model 23 79.81 model 26 91.03
model 30 1 model 32 87.93 model 31 92.53
model 32 1 model 31 113.46 model 32 102.04
model 33 1 model 30 113.52 model 22 103.86
model 22 0 model 35 113.7 model 35 106.39
model 31 0 model 22 114.01 model 30 109.48
model 34 0 model 34 139.77 model 34 131.81
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Table B.2.: AIC values for each model and each fit of data set 1. k corresponds to the number of parameters of each model.
Model k Fit 1 Fit 2 Fit 3 Fit 4 Fit 5 Fit 6 Fit 7 Fit 8
model 1 17 75.76 72.31 102.15 72.75 -168.51 151.97 75.18 74.96
model 2 15 66.49 42.27 43.49 70.59 141.54 34.08 44.04 44.18
model 3 17 85.76 87.83 102.78 101.3 -188.39 -201.82 99.19 73.9
model 4 15 65.51 61.65 52.34 70.85 141.71 -84.34 39.53 40.37
model 5 15 66.49 70.17 49.62 70.67 141.79 -236.58 39.66 67.91
model 6 17 88.55 87.81 107.55 90.33 -111.42 137.04 70.08 129.06
model 7 15 73.8 61.52 55.57 63.72 141.73 -34.18 64.34 40.04
model 8 17 101.9 89 83.9 102 -102.57 103.07 75.21 75.3
model 9 15 61.93 59.28 59.19 69.98 -111.68 -177.67 44.32 69.47
model 10 15 65.7 64.63 59.19 69.95 141.76 76.48 69.45 72.48
model 11 18 118.91 94.31 119.03 95.44 -257.13 -12.14 97.74 89.28
model 12 16 75.2 83.98 83.94 75.34 145.57 -11.37 58.89 50.49
model 13 18 116.33 109.95 102.04 112.27 -198.55 -94.29 95.14 93.14
model 14 16 63.65 63.86 81.38 84.95 -188.06 141.98 53.69 53.06
model 15 16 79.36 59.69 79.41 80.45 -146.97 -95.81 53.89 54.63
model 16 17 93.47 100.81 99.31 90.4 -112.79 -111.21 64.72 103
model 17 13 34.76 24.93 51.33 48.9 17.46 148.03 8.13 11.63
model 18 17 84.86 106.53 87.06 84.32 -200.3 71.4 75.41 76.02
model 19 15 52.29 51.91 74.59 53.12 -209.36 -123.96 43.93 69.8
model 20 15 60.51 54.31 74.52 74.73 -125.31 104.94 44.46 64.91
model 21 13 39.3 33.43 34.64 39.01 -145.21 89.47 45.43 24.28
model 22 17 106.77 100.95 110.48 106.99 152.19 145.61 96.18 96.06
model 23 15 75.43 74.55 70.2 75.09 146.31 -222.13 69.45 64.09
model 24 17 106.77 86.29 87.6 106.97 -116.3 -54.72 71.6 84.89
Continued on next page
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Model k Fit 1 Fit 2 Fit 3 Fit 4 Fit 5 Fit 6 Fit 7 Fit 8
model 25 15 59.04 74.55 58.5 74.83 -156.15 104.19 39.98 70.14
model 26 17 99.47 100.79 96.86 90.3 147.62 89.87 90.56 90.59
model 27 15 59.68 55.75 73.23 58.3 -116.13 -20.66 77.3 60.08
model 28 15 63.66 61.52 61.71 64.06 141.87 -148.46 77.3 77.29
model 29 13 42.45 39.61 39.83 48.82 -13.91 -190.38 38.15 42.6
model 30 17 99.04 97.88 97.88 98.94 150.55 -156.83 109.3 109.41
model 31 15 69.98 65.89 70.87 70.66 141.76 147.62 77.31 78.3
model 32 17 102.61 101.47 127.64 96.47 -100.97 79.8 94.89 109.28
model 33 15 66.74 59.45 66.35 85.66 -108.06 -199.63 61.81 67.76
model 34 17 106.77 106.54 106.54 106.82 152.14 154.63 109.29 109.32
model 35 13 53.58 52.54 56.58 52.86 142.3 207.94 55.31 70.48
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Table B.3.: AIC values for each model and each fit of data set 2. k corresponds to the number of parameters of each model.
Model k Fit 9 Fit 10 Fit 11 Fit 12 Fit 13 Fit 14 Fit 15 Fit 16
model 1 17 89.42 77.38 -189.98 -176.76 -184.72 -180.29 -177.43 -251.85
model 2 15 38.01 47.1 -195.85 100.04 51.45 -87.21 45.02 -101.44
model 3 17 79.2 77.84 -60.66 -228.31 -114.27 135.51 41.88 -190.72
model 4 15 44.56 45.44 123.59 -221.26 -8.64 -180.57 -0.92 147.55
model 5 15 78.13 67.51 123.44 27.34 179.79 131.54 58.29 145.79
model 6 17 70.9 70.56 -235.1 -198.09 -205.23 -234.37 -48.45 -87.72
model 7 15 64.63 46.6 -185.87 87.43 1 148.87 147.29 -3.89
model 8 17 102.54 77.48 -196.49 -178.64 22.93 -179.49 53.48 -147.54
model 9 15 71.05 47.11 -347.03 -104.49 -14.89 -87.24 45.79 147.59
model 10 15 77.4 77.19 -182.33 67.63 56.73 82.69 100.88 147.21
model 11 18 97.55 99.25 -99.04 17.37 -317.49 -181.27 -58.57 -233.11
model 12 16 59.66 61.13 -189.68 -189.38 59.43 -85.46 150.99 -66.01
model 13 18 97.59 121.8 -216.04 -226.7 -160.44 -218.72 -108.59 -87.55
model 14 16 58.9 81.72 -214.1 55.05 29.83 -183.39 54.82 12.68
model 15 16 57.86 81.75 -227.13 65.23 -173.7 -182.09 26.54 -63.34
model 16 17 77 77.53 -196.47 -200.54 -178.91 -345.64 -90.59 -252.67
model 17 13 14.04 45.57 -105.39 -217.08 -4.78 -298.74 30.56 19.37
model 18 17 95.84 77.42 -194.96 -194.24 -185.41 -183.91 -197.15 -194.74
model 19 15 51.53 70.42 -200.06 118.07 -187.29 -183.81 -199.39 151.22
model 20 15 50.78 67.55 125.14 124.82 -16.72 -87.43 56.55 151.85
model 21 13 25.05 45.52 -101.19 -98.92 126.29 -91.58 124.83 150.6
model 22 17 96.54 96.67 82.47 81.74 85.78 151.77 156.98 157.04
model 23 15 66.32 69.92 140.46 108.69 88.44 148.07 150.98 151.12
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Model k Fit 9 Fit 10 Fit 11 Fit 12 Fit 13 Fit 14 Fit 15 Fit 16
model 24 17 76.07 77.8 -223.55 153.27 -183.06 -181.62 156.98 157.02
model 25 15 69.73 45.38 -224.73 -216.22 44.73 -182.26 151.33 151.33
model 26 17 106.9 91.47 -34.12 184.6 122.63 -40.72 -66.04 -87.51
model 27 15 77.55 58.8 -38.29 -38.5 31.58 -40.35 -78.83 146.63
model 28 15 77.59 77.64 -23.76 176.45 184.43 185.28 -4.03 -3.23
model 29 13 43.08 55.6 -16.76 -18.49 108.43 181.36 143.28 143.91
model 30 17 109.55 109.61 184.21 169.31 187.84 188.88 106.69 154.12
model 31 15 77.59 77.6 180.09 132.96 184.49 185.35 106.77 148.2
model 32 17 97.59 109.59 184.16 -2.78 125.26 188.91 -56.3 149.24
model 33 15 77.56 77.6 180.13 182.22 186.05 185.33 3.14 -32.05
model 34 17 111.49 109.61 184.63 185.49 189.39 189.12 157.28 157.22
model 35 13 55.63 55.68 176.97 179.2 184.66 181.28 147.15 147.07
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C. Microarray data analysis
Mice macrophages were stimulated Av17, E1 (Active peptide of Av17, responsible
for IL-10 production) and Cysele (cystatin of C. elegans). Total RNA was extracted
from the macrophages at 24 hours after stimulation with Av17, E1 or Cysele. Samples
were hybridised in the Affymetrix microarray chip MG4302.0. Data normalisation,
as well as differential gene expression, were done using Bioconductor (http://www.
bioconductor.org/about/) and R (http://www.r-project.org).
C.1. Differential gene expression
C.1.1. Cysele vs. Av17
Method:
• Select the present genes from the complete list of genes;
• Compute FC = log
(
Cysele
Av17
)
;
• Select genes, such that |FC| > 1.5;
• Genes that have a positive FC value, are upregulated in Cysele; genes that
have a negative FC value, are upregulated in Av17.
Table C.1.: Differential gene expression. FC positive values represent the upregu-
lated genes in Cysele and FC negative values represent the upregulated
genes in Av17.
FC Gene Gene description GenBank ID
3.54 Mrps14 M. musculus mitochondrial ribosomal protein
S14
NM_025474.1
3.28 Il1b M. musculus, similar to interleukin 1 beta NM_008361.1
2.70 - Moderately similar to CDA11 protein (H.sapiens) BB761179
2.29 Lfng M. musculus adult male lung cDNA (lunatic
fringe gene homolog)
AK004642.1
2.24 Scyb2 small inducible cytokine subfamily, member 2 NM_009140.1
Continued on next page
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FC Gene Gene description GenBank ID
2.18 Cish3 cytokine inducible SH2-containing protein 3 BB241535
2.14 Serpinb2 M. musculus serine (or cysteine) proteinase in-
hibitor
NM_011111.1
2.11 Rassf1 ras association (RalGDSAF-6) domain family 1 NM_019713.1
2.10 Fn1 fibronectin 1 BM234360
2.09 Mlp MARCKS-like protein AV215438
2.08 Dab2 unknown (protein for MGC:18401) BC006588.1
2.06 Cmkbr2 M. musculus chemokine (C-C) receptor 2 U51717.1
NM_009915.1
U56819.1
U47035.1
2.03 Cmkbr5 M. musculus chemokine (C-C) receptor 5 NM_009915.1
2.02 Swap2-
pending
suppressor of white apricot homolog 2-pending -
2.01 Cmkbr2 M. musculus JE receptor (chemokine (C-C motif)
receptor 2)
U51717.1
NM_009915.1
U56819.1
U47035.1
2.00 Cpne3 copine III -
1.95 Fbxl5 f-box and leucine-rich repeat protein 5 -
1.91 Calm1 M. musculus calmodulin 1 -
1.90 Nfil3 M. musculus embryo implantation related
NFIL3E4BP4-like transcription factor
AY061760.1
NM_017373.1
1.88 Olfm1 M. musculus mRNA for pancortin-3 AF028740.1
D78264.1
1.87 Timp M. musculus, Similar to tissue inhibitor of met-
alloproteinase
BC008107.1
M17243.1
NM_011593.1
1.81 Ywhaz tyrosine 3-monooxygenasetryptophan 5-
monooxygenase activation protein, zeta polypep-
tide
-
1.80 M. musculus mRNA for C-C chemokine receptor
5
U47036.1
D83648.1
1.78 Cish3 cytokine inducible SH2-containing protein 3 BB831725
1.71 Gro1 M. musculus GRO1 oncogene NM_008176.1
J04596.1
Continued on next page
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FC Gene Gene description GenBank ID
1.70 Ikbkg inhibitor of κB kinase gamma AF069542.1
BC021431.1
NM_010547.1
1.68 M. musculus, Similar to peroxisomal biogenesis
factor 6
1.68 Scya24 M. musculus eotaxin-2 NM_019577.1
AF281075.1
AF244367.1
1.68 Ldlr M. musculus low density lipoprotein receptor AF425607.1
BC019207.1
NM_010700.1
1.68 Gpaa1 GPI anchor attachment protein 1 -
1.67 - M. musculus, Similar to cortactin isoform B -
1.67 Col3a1 procollagen, type III, alpha 1 -
1.67 M. musculus, Similar to pM5 protein BC024503.1
1.66 Smpdl3b sphingomyelin phosphodiesterase, acid-like 3B AU045240
1.66 Oxsm 3-oxoacyl-ACP synthase, mitochondrial C80494
1.66 Dcn M. musculus decorin mRNA NM_007833.1
1.65 angie2 M. musculus CXC chemokine AF030636.1
BC012965.1
AF044196.1
NM_018866.1
1.64 Cish3 M. musculus cytokine inducible SH2-containing
protein 3
NM_007707.1
1.64 Scya2 M. musculus strain NODLtJ small inducible cy-
tokine A2 precursor
NM_011333.1
1.63 Weakly similar to TYROSINE-PROTEIN KI-
NASE JAK3
BB460570
1.63 Smurf1 SMAD specific E3 ubiquitin protein ligase 1 -
1.62 Serpinh1 serine (or cysteine) proteinase inhibitor, clade H
(heat shock protein 47)
NM_009825.1
1.61 Clecsf10 M. musculus strain BALBc dectin-2 beta isoform AF240358.1
1.61 Ubc ubiquitin C -
1.61 Mmp19 matrix metalloproteinase 19 NM_021412.1
1.61 Tmem87b transmembrane protein 87B AU014804
1.60 Cmkbr1 chemokine (C-C) receptor 1 U29678.1
NM_009912.1
BC011092.1
Continued on next page
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FC Gene Gene description GenBank ID
1.59 Mmp19 M. musculus matrix metalloproteinase 19 NM_021412.1
AF162446.1
AF153199.1
AF155221.1
1.59 Ltbp3 latent transforming growth factor beta binding
protein 3
-
1.58 Arg1 M. musculus arginase 1, liver NM_007482.1
U51805.1
BC013341.1
1.58 Actb M. musculus actin, beta, cytoplasmic J04181.1
NM_007393.1
1.58 Serpinb1 M. musculus EIA Serpin mRNA NM_025429.1
BC011140.1
AF426024.1
1.57 Nedd4a neural precursor cell expressed, developmentally
down-regulated gene 4a
U96635.1
1.57 Map2k2 mitogen activated protein kinase kinase 2 BC014830.1
NM_023138.1
1.57 Myo1h M. musculus myosin IH NM_026145.1
1.56 Neo1 neogenin NM_008684.1
1.56 Col3a1 procollagen, type III, alpha 1 -
1.56 Actn1 M. musculus, clone IMAGE:3483627 -
1.55 Selel selectin, endothelial cell, ligand NM_009149.1
BC021306.1
1.55 Abcc5a M. musculus ATP-binding cassette protein -
1.55 Tex189 testis expressed gene 189 -
1.55 Sh3bp1 M. musculus SH3-domain binding protein 1 NM_009164.1
BC004598.1
1.55 Gas5 M. musculus, similar to growth arrest specific 5 BC004622.1
1.54 Scyb5 M. musculus small inducible cytokine B subfam-
ily, member 5
BC024392.1
U27267.1
NM_009141.1
1.54 Cp M. musculus ceruloplasmin U49430.1
NM_007752.1
Continued on next page
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FC Gene Gene description GenBank ID
1.54 Cd86 M. musculus, CD86 antigen AF065897.1
AF065900.1
AF065899.1
AF065898.1
BC013807.1
NM_019388.1
L25606.1
1.54 Hif1a hypoxia inducible factor 1, alpha subunit BC026139.1
NM_010431.1
AF003695.1
1.54 Tcfec M. musculus transcription factor EC AF077742.1
NM_031198.1
1.54 Ppic M. musculus peptidylprolyl isomerase C BC025861.1
M74227.1
NM_008908.1
1.52 Enpp2 M. musculus, ectonucleotide pyrophos-
phatasephosphodiesterase 2
BC003264.1
AF123542.1
NM_015744.1
1.52 Rbp M. musculus retinol binding protein 1, cellular BC018254.1
NM_011254.1
1.51 Nisch nischarin -
1.51 Dab2 M. musculus disabled homolog 2 (Drosophila) NM_023118.1
-1.51 Fabp3 M. musculus fatty acid binding protein 3, muscle
and heart
U02883.1
BC002082.1
NM_010174.1
-1.51 Mmp9 M. musculus matrix metalloproteinase 9 D12712.1
NM_013599.1
-1.51 Abin M. musculus A20 binding inhibitor of NF-kappaB
activation-2
NM_139064.1
-1.51 Ifit2 M. musculus interferon-induced protein with
tetratricopeptide repeats 2
NM_008332.1
U43085.1
-1.51 Pxf M. musculus, peroxisomal farnesylated protein NM_023041.1
BC019767.1
-1.51 Tst M. musculus, thiosulfate sulfurtransferase, mito-
chondrial
NM_009437.1
BC005644.1
U35741.1
-1.51 Isg12 M. musculus interferon stimulated gene 12 AY090098.1
Continued on next page
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FC Gene Gene description GenBank ID
-1.52 Dusp19 M. musculus dual-specificity phosphatase 19 AB038769.1
BC021591.1
AF237618.1
NM_024438.1
-1.52 Acas1 M. musculus acetyl-Coenzyme A synthetase 1
(AMP forming)
AF216873.1
NM_019811.1
-1.52 - M. musculus adult male testis, homolog to SER-
INE PHOSPHATASE
-
-1.54 Rps27 ribosomal protein S27 -
-1.55 Slc41a3 solute carrier family 41, member 3 AI480742
SLC41A1-L2
-1.55 - solute carrier family 35 (UDP-galactose trans-
porter), member 2
-
-1.56 Slamf7 M. musculus adult male testis cDNA, Novel LY9
(Lymphocyte antigen 9) NK Cell receptor, SLAM
family member 7
-
-1.56 Zbtb44 zinc finger and BTB domain containing 44 -
-1.56 Faim3 M. musculus 10 day old male pancreas, homolog
to anti Fas induced apoptosis, Fas apoptotic in-
hibitory molecule 3
MGC144825
MGC144826
-1.56 Ercc4 M. musculus excision repair cross-complementing
rodent repair deficiency, complementation group
4
AF189285.1
NM_015769.1
BC026792.1
-1.56 Tns M. musculus tensin NM_027884.1
-1.57 Paics phosphoribosylaminoimidazole carboxylase,
phosphoribosylaminoribosylaminoimidazole,
succinocarboxamide synthetase
-
-1.57 Scya22 M. musculus, Similar to small inducible cytokine
subfamily A, member 22
FL=AF052505.1
BC012658.1
NM_009137.1
AF163476.1
AF076596.1
-1.58 S100a1 M. musculus, S100 calcium binding protein A1 AF087687.1
NM_011309.1
BC005590.1
-1.61 Pja1 praja1, RING-H2 motif AF335250.1
Continued on next page
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FC Gene Gene description GenBank ID
-1.62 Rbx1 M. musculus, ring-box 1 BC027396.1
AF140599.1
NM_019712.1
-1.62 Tmem41b transmembrane protein 41B AU018901
MGC38847
D7Ertd70e
D7Ertd743e
-1.63 Hai2 M. musculus hepatocyte growth factor activator
inhibitor type 2 splice variant 2
AF099020.1
-1.64 Gtf2ird2 M. musculus GTF2I repeat domain containing 2 -
-1.65 Cbfa2t3h core-binding factor, runt domain, alpha subunit
2; translocated to, 3 homolog (human)
-
-1.66 Ywhaq tyrosine 3-monooxygenasetryptophan 5-
monooxygenase activation protein, theta
polypeptide
-1.68 Usp18 M. musculus ubiquitin specific protease 18 NM_011909.1
AF069502.1
-1.70 IgG3 M. musculus germline imunoglobulin gamma con-
stant region
-
-1.70 Pafah1b3 M. musculus platelet-activating factor acetylhy-
drolase, isoform 1b, alpha1 subunit
U57746.1
NM_008776.1
-1.71 Brd4 M. musculus, similar to bone marrow stromal cell
antigen 2
BC027328.1
-1.72 H28 M. musculus histocompatibility 28 (H28) AF336221.1
NM_031367.1
-1.72 Dhcr24 M. musculus, similar to dual specificity phos-
phatase 9
BC004738.1
KIAA0018
-1.73 Zadh1 zinc binding alcohol dehydrogenase, domain con-
taining 1
AI838763
-1.76 Manbal M. musculus Manbal mannosidase, beta A,
lysosomal-like
AI836500
-1.84 Ppicap M. musculus peptidylprolyl isomerase C-
associated protein
L16894.1
NM_011150.1
-1.87 IgL M. musculus Igl-V1 immunoglobulin lambda
chain, variable 1
-
-1.88 Fkbp4 M. musculus, FK506 binding protein 4 NM_010219.1
BC003447.1
-2.11 Siah1a seven in absentia 1A NM_009172.1
Continued on next page
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FC Gene Gene description GenBank ID
-2.11 Sts M. musculus steroid sulfatase NM_009293.1
U37545.1
-2.12 Ptdss2 phosphatidylserine synthase 2
-2.52 Scya5 M. musculus small inducible cytokine A5 AF128187.1
AF065944.1
NM_013653.1
M77747.1
AF065947.1
AF065946.1
AF065945.1
-2.54 Polr3k polymerase (RNA) III (DNA directed) polypep-
tide K
AI196849
AU014893
C.1.2. Cysele vs. (Av17 AND E1)
Method:
• Select the present genes from the complete list of genes;
• Compute FC1 = log
(
E1
Av17
)
;
• Select the genes with FC1 ∼ 0 (E1Av17 - genes with similar expression in E1
and Av17);
• Compute FC2 = log
(
Cysele
Av17
)
;
• Select genes, such that |FC2| > 1.5;
• Genes that have a positive FC2 value, are upregulated in Cysele; genes that
have a negative FC value, are upregulated in the group E1Av17.
Table C.2 shows the resulting genes of this analysis.
C.2. Gene ontology
Gene ontology is an international standard to annotate genes and gene products
(Ashburner et al., 2000). I used the software GOSSIP (Blüethgen, 2005) to test
which gene ontology groups are significantly enriched in the group of genes previously
presented. The significantly enriched groups are present in Table C.3.
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C.3. Outlook
Genes upregulated in E1Av17
M. musculus, platelet-activating factor acetylhydrolase,isoform 1b,
alpha1 subunit (Pafah1b3)
M. musculus, S100 calcium binding protein A1 (S100a1)
dual-specificity phosphatase (5930436K22Rik)
M. musculus steroid sulfatase (Sts)
M. musculus germline immunoglobulin gamma constant region (IgG3)
M. musculus tensin (Tns)
Genes upregulated in Cysele
M. musculus EIA (Serpinb1)
M. musculus GRO1 oncogene (Gro1)
M. musculus transcription factor EC (Tcfec)
M. musculus arginase 1, liver (Arg1)
chemokine (C-C) receptor 1 (Cmkbr1)
M. musculus small inducible cytokine B subfamily, member 5 (Scyb5)
M. musculus mitochondrial ribosomal protein S14 (Mrps14)
M. musculus chemokine (C-C) receptor 5 (Cmkbr5)
M. musculus mRNA for pancortin-3 (Olfm1)
M. musculus mRNA for C-C chemokine receptor 5 (CCR5)
M. musculus, Similar to nucleolar GTPase (gb:BM199850)
suppressor of white apricot homolog 2-pending (Swap2-pending)
f-box and leucine-rich repeat protein 5 (Fbxl5)
M. musculus ras association (RalGDSAF-6) domain family 1 (Rassf1)
M. musculus, Similar to interleukin 1 beta (Il1b)
M. musculus small inducible cytokine subfamily, member 2 (Scyb2)
M. musculus low density lipoprotein receptor mRNA (Ldlr)
M. musculus, Similar to pM5 protein (gb:BC024503.1)
M. musculus, Similar to tissue inhibitor of metalloproteinase (Timp)
Table C.2.: Differential gene expression of Cysele and E1Av17 (genes with similar expression
in E1 and Av17) .
C.3. Outlook
Further microarray data can complement this analysis in two ways. First, to better
understand which genes are involve in IL-10 production and regulation: expose mice
macrophages to Av17 and extract the RNA at the time points 1h, 2h, 4h, 8h. As
control, extract RNA of macrophages and medium, at the same time point. These
time points picture the dynamics of the RNA expression of Il10 and Dusp1, present
in Figures 4.3(a) and 11.1, respectively. Second, to better understand the genotype
of Av17 stimulated macrophages: extract RNA from Av17 stimulated macrophages,
macrophages without stimuli and M2 macrophages. This approach could help char-
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C. Microarray data analysis
GO Term Name FDR
5578 extracellular matrix (sensu Metazoa) 3.62E-06
31012 extracellular matrix 3.62E-06
5576 extracellular region 3.81E-05
45202 synapse 4.02E-05
5509 calcium ion binding 4.02E-05
5887 integral to plasma membrane 0.000333
45211 postsynaptic membrane 0.000333
19226 transmission of nerve impulse 0.000333
31226 intrinsic to plasma membrane 0.000333
7268 synaptic transmission 0.000384
16503 pheromone receptor activity 0.001338
7606 sensory perception of chemical stimulus 0.001629
50877 neurophysiological process 0.001629
16021 integral to membrane 0.001927
31224 intrinsic to membrane 0.002631
5615 extracellular space 0.003511
5230 extracellular ligand-gated ion channel activity 0.005233
7156 homophilic cell adhesion 0.005233
7267 cell-cell signaling 0.010298
Table C.3.: GO terms extracted by the software package GOSSIP, for the list of genes of
table C.1. FDR stands for false discovery rate and gives an estimate of the proportion of the
expected number of false discoveries, for a given p-value (Blüethgen, 2005). Groups with a
FDR>0.01 were rejected.
acterising the type of macrophage induced by Av17 and, furthermore, the effect of
these cells on other cells and on the immune system in general.
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D. Abbreviations
Abbreviation Description
A. viteae Acanthocheilonema viteae
AIC Aikaike information criterion
AU arbitrary units
Av17 cystatin from A. viteae (GenBank: L43053.1)
CREB cAMP responsive element binding protein 1
dusp dual specificity phosphatase mRNA
DUSP dual specificity phosphatase protein
dusp1−/− dusp1 knockout mice
ERK extracellular signal-regulated kinase
H3 histone 3
il-10 interleukin-10 mRNA
il-10−/− interleukin-10 knockout mice
IL-10 interleukin-10 protein (GenBank: CAG46825.1)
JNK c-Jun N-terminal kinase
LPS lipopolysaccharide
MAPK mitogen-activated protein kinase
MKP mitogen-activated protein kinase phosphatase
O.volvulus Onchocerca volvulus
ODE ordinary differential equation
rAV17 recombinant cystatin from A. viteae
RSS residual sum of squares
SP1 Sp1 transcription factor
STAT3 signal transducer and activator of transcription
wt wild type
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